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ABSTRACT
Borrelia burgdorferi is an enigmatic bacterial pathogen that afflicts a large
proportion of the world population as the causative agent of Lyme disease. The
bacterium has a number of factors that promote virulence including a complex and
dynamic array of extracellular proteins that can interact with various molecules of
an infected host. One such molecule, fibronectin, is a key glycoprotein in the ECM of
mammalian hosts with multiple characterized functions. B. burgdorferi encodes
multiple known Fn-binding proteins, and has an additional putative protein BB0347
that may also bind Fn. Another protein, MlpJ, is homologous to a known heminbinding protein, which is curious, as iron, the element carried by the hemin
molecule, is not essential for spirochete survival. In the included studies, we sought
to characterize the function and importance of these two bacterial proteins, BB0347
and MlpJ, using various molecular, biochemical, and biomedical techniques. Such
methods included the production and purification of recombinant proteins and
corresponding antibodies; development of mutant B. burgdorferi strains, various
immunohistochemical assays, and the infection of inbred laboratory mice and Ixodes
ticks with virulent B. burgdorferi strains followed by subsequent molecular and
culture-based analyzes of infected specimens. We verified that both proteins were
surface exposed and capable of performing their hypothesized functions (Fn binding
for BB0347 and hemin binding for MlpJ). In addition, BB0347 interacts with human

ix

fibronectin via multiple domains, enhances the adherence capabilities of intact
spirochetes, and allows for an increased bacterial load in various tissues at an early
time point in the mouse infection model. Additionally, while MlpJ binds to the ironcontaining molecule hemin, this interaction negatively affects bacterial survival in
vitro after a hemin challenge but doesn’t impact bacterial fitness in the same mouse
model at any of the times measured. Overall, we hope that advances made in these
proteins may help further characterize the processes and dynamics of a human
infection with B. burgdorferi, which may, in turn, lead to advances in treatment
techniques for Lyme disease as well as other bacterial infections.
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CHAPTER I
INTRODUCTION
Lyme disease
Lyme disease is an emerging infectious disease (1, 2), and affects a large
proportion of the world, mostly in the northern hemisphere (3, 4). Approximately
20-30,000 cases are reported per year in the United State alone (5), which make
Lyme disease the seventh most common reportable disease, and the most common
vector-borne disease in the US (6) as well as in Western Europe (7). Furthermore,
estimates for the actual caseload per year suggest that the total number of Lyme
cases in the United States as approximately 300,000; a tenfold increase from the
number of cases actually reported to the Centers for Disease Control and Prevention
(6). This high caseload results in a cost per year of approximately $1 billion per
year in the United States alone (8).
Lyme disease can manifest in a number of clinical outcomes. The most
common result of a Lyme infection is the presence of the bull’s-eye rash known
clinically as erythema migrans, although patients with Lyme disease do not always
display or notice this symptom, potentially complicating a diagnosis (9, 10). The
disease can also manifest as a rheumatoid-like arthritis (Lyme arthritis), most
commonly affecting large joints such as the knee. Cardiac and neurological
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manifestations of Lyme disease are less common, but have the capacity for some of
the most serious outcomes of the disease. Lyme disease has even been implicated in
death of susceptible patients after causing cardiac distress (11, 12). While this
outcome is rare, it is also possible that deaths resulting from a Lyme infection are
underreported (12). A current challenge facing Lyme researchers is the persistence
of symptoms following antibiotic treatment in a small subset of individuals, who are
classified as having post-treatment Lyme disease syndrome. While extended
antibiotic treatment regiments have been tested in the past, meta-analyses of the
data have concluded that this extended antibiotic treatment is not effective
eliminating these post-treatment Lyme-like symptoms (13, 14). Also, although
these patients appear to present with Lyme disease-like symptoms after antibiotic
treatment, no conclusive evidence has been presented that live bacteria are present
in the affected patients (15). The phenomena driving these pathologies are,
therefore, a potentially important focus of research.
It is also important to note that, while Lyme disease is an important problem
in the United States, the disease is endemic across the Northern hemisphere,
including parts of Canada (3, 4), as well as various countries in Europe (16, 17) and
Asia (18). Lyme disease is caused, worldwide, by a genus of bacteria that are
members of the Borrelia burgdorferi sensu lato group.

Spirochetes and B. burgdorferi sensu lato
B. burgdorferi sensu lato species belong to a group of bacteria known as
spirochetes (order Spirochaetales). A number of clinically important bacteria
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belong to the Spirochaetales order in addition to the Lyme spirochetes, such as
Leptospira sp. (the causative agents of leptospirosis) and Treponema pallidum
(syphilis), although multiple factors differentiate the genera within this family (19).
One factor spirochetes have in common is the presence of endocellular flagella, of
varying number per cell.
B. burgdorferi sensu lato itself is a group of highly motile bacteria with flat
wave morphologies. The different species of Borrelia show diverging tropism for
varied host types, and also have varying patterns of distribution, although the
ranges of many of the species overlap in Europe, where several Borrelia are
endemic, including B. afzelii (17), B. garinii (20) and B. burgdorferi sensu stricto. In
the United States, the later is the only known Lyme spirochete, and is simply
referred to as B. burgdorferi. One additional new species, B. mayonii, has been
characterized in the US that causes a Lyme-like disease with some key differences
(21, 22).

B. burgdorferi life cycle and transcriptional regulation
B. burgdorferi is an obligate pathogen (23), and the spirochete has never
been isolated outside of an infected host outside of the laboratory. To propagate in
nature, B. burgdorferi is transmitted between its preferred hosts, which are small
mammals, by Ixodes ticks (21, 24). Ixodes is a genus of small, hard-shelled ticks
endemic to both the United States (25–27) and Eurasia (16, 20, 28), colloquially
referred to as a deer ticks. Once in a competent mammalian host, B. burgdorferi may
establish a lifelong infection, but is unable to cross the placental barrier (23). Thus,
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animals born from a B. burgdorferi-infected animal are not themselves infected. The
only mechanism by which B. burgdorferi has to spread is the aforementioned Ixodes
tick. A successful population of B. burgdorferi in the natural environment, therefore,
requires an endemic population of this arachnid vector. In order to be infected, an
animal must be bitten by an Ixodes tick that fed on a previously infected animal.
This is important in determining disease dynamics as well as etiology.
This two-host lifestyle requires that the bacterium adapt to each host as a
distinct ecological niche. Appropriately, B. burgdorferi has evolved a number of
adaptations that enable it to 1. sense which host they are in, 2. activate the factors
that allow for survival in the current host, and 3. detect when the bacterium needs
to transition to a new host. For example, when infecting an Ixodes tick, B.
burgdorferi must express outer surface protein A (OspA), which allows the
spirochete to bind to the appropriate tick receptor (tick receptor for OspA—
TROSPA) and allows for persistence (29–31). When the tick feeds on an infected
animal, the spirochete must “turn off” the gene for OspA, and instead produce outer
surface protein C (OspC) (32). OspC is essential for bacterial growth in the
mammalian host, and the function of the protein remains incompletely
characterized (33–35). The response of B. burgdorferi to the appropriate host is
modulated by a number of factors. One such factor is the RpoN/RpoS RNA
polymerase cascade (36, 37). RpoN is an alternative sigma factor (σ54) subunit of
RNA polymerase (RNAP) activated upon acquisition of a blood meal by the host tick
in part by the response regulator Rrp2, a member of a two-component sensory
transduction system (38–42). This σ54RNAP in turn activates the transcription of
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the rpoS gene, leading to the production of RpoS (σs), which controls many of the
genes necessary for the infection of the mammalian host by B. burgdorferi (42–45).
However, this sigma factor cascade is not the only pathway responsible for control
of the genes responsible for mammalian colonization. Current literature suggests
that many factors are likely to play a role in the spirochete’s response to host
conditions (46). For example, the aforementioned ospC gene must be
transcriptionally inactivated after a successful colonization of the mouse host one
month after infection, or the pathogen will be cleared from the host’s tissues (34).

The immune response to B. burgdorferi
B. burgdorferi is well adapted to its ecological niche in that it has a number of
factors that prevent its recognition and clearance from an immune response.
Although the bacterium appears like a gram-negative bacterium, with a double lipid
membrane and thin peptidoglycan layer, B. burgdorferi does not possess the classic
gram-negative molecule know as lipopolysaccharide (LPS) (47, 48). This may help
the bacterium prevent an immune response, as LPS is highly immunostimulatory,
and activates a highly potent immune reaction by signaling through Toll-Like
receptor 4 (TLR4) (49, 50). Interestingly, the gene for TLR4 is up-regulated in
mammals infected with B. burgdorferi even though this receptor is hypothesized to
lack a role in a Lyme infection (51). One host receptor that is known to be
important in a B. burgdorferi infection is another Toll-like receptor, TLR2 (51–53).
TLR2 recognizes bacterial lipoproteins via their Pam-3-Cys domains and stimulates
an immune response by activating the transcription factor NF-kB, thereby activating
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the genes for multiple chemokines and cytokines to initiate and sustain an immune
response (54).
In many bacterial systems, extracellular factors such as complement and
opsonization by antibodies can eliminate bacteria without necessitating uptake by
professional phagocytes (55). However, B. burgdorferi has adopted a number of
systems that can mitigate these normally toxic phenomena. To evade complementmediated killing, the spirochete will bind to a number of host proteins that prevent
complement from killing host cells. The described factors that allow this are
numerous and include the Erp family of proteins and CRASP-1, which interact with
the complement regulator factor H (56–60). One mechanism by which B.
burgdorferi controls antibody recognition is by using a decoy protein, variable
lipoprotein surface exposed (VlsE). VlsE acts as a target for antibody production by
having a high degree of antigenicity, and then switches regions of the protein via the
use of variability cassettes, ensuring that not all of the bacteria in a population are
recognized uniformly (61–63). Even when the VlsE proteins are recognized by
antibodies, these proteins may act as decoys to prevent the opsonization of other
proteins with important functions, thereby ensuring that those necessary proteins
are able to act as intended.
All of these adaptations together create a pathogen that must be endocytosed
directly by a phagocytic cell in order to control bacterial growth. However, even this
is a challenge for host immune cells. As mentioned previously, B. burgdorferi is a
flat-wave-shaped bacterium, and this shape allows the bacterium to traverse dense,
viscous tissue, such as that found in a host’s extracellular matrix (ECM), very
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effectively. Bacteria lacking the FlaB protein that grants this shape and
accompanying motility are non-infectious (64). In fact, bacteria with FlaB are able
to move through tissue much more rapidly than any sentinel immune cell would be
able to—3000 microns/min at top speed—nearly 100 times faster than human
neutrophils (65). In addition to its shape, B. burgdorferi must also bind to and
rearrange components of the ECM to facilitate this rapid movement (66), and the
bacterium has evolved a number of proteins able to carry out interactions with a
wide variety of ECM proteins. Interaction of the spirochete with ECM proteins, and
the distinct shape of the bacterium together contribute to the smooth movement of
the pathogen through the mammalian host. Smoother, in fact, than a double pour of
single-pot Irish whiskey past a thirsty man’s lips.

The extracellular matrix
The mammalian ECM is a complex system of various molecule types that
function to promote cellular adhesion, signaling, and migration (67). Multiple
members of the ECM are essential for proper organism development and function.
The two main subdivisions of the ECM in mammals are the basement membrane
(68, 69) and the interstitial matrix . Collagens are the most abundant fibrous ECM
component, composing up to 30% of the protein content of an entire mammal (70)
and are divided into multiple families of varying function that are too numerous to
elaborate on here (71). Another class of important ECM molecules are
glycosaminoglycans (GAGs). These molecules are constituted of long chains of
polysaccharides formed by repeating amino sugars linked to uronic sugars.
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Examples of GAGs included heparin sulfate, keratin sulfate, and hyaluronic acid
(72); all of which have been shown to have a number of functions in healthy
mammals as well as in disease states such as tumorogenesis (73). The specific roles
of GAGs in mammalian hosts are, likewise, diverse, and include signaling, cell
adhesion, and water retention (70, 72). Often GAGs form a subunit of large
complexes known as proteoglycans. One such proteoglycan, decorin, is another
member of the ECM, again fulfilling various functions including matrix assembly,
fibrilogenesis and angiogenesis (74–76). One of the ways that decorin, among other
ECM components performs some of its functions is through interaction with the
glycoprotein fibronectin (77, 78).
Fibronectin (Fn) is an ubiquitous component of the ECM, and is found in
nearly all tissue types. Fn exists in two states, first, as a soluble molecule in
plasma—Fn is one of the most abundant protein components of human plasma, with
concentrations of approximately 300µg/mL (79)—and also as an insoluble cellular
form. The primary sources for these two species of Fn are hepatocytes and
fibroblasts, respectively (79–81). Fibronectin is a large glycoprotein, existing in its
soluble form as a dimer comprised of two subunits weighing 220-250 kDa each. The
reason for the large size is the diversity of distinct functions that each molecule of
Fn can perform. These functions are facilitated by the numerous domains of the
protein, each of which is able to bind multiple ECM components—including other
molecules of Fn (82–84). These multiple domains enable Fn to act as a bridge
between the many types of ECM proteins, analogous to mortar holding various
construction materials in place (85, 86). Among the other ECM components that Fn
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is known to bind are fibrin, fibronectin, collagen, heparin, and integrins (82, 83, 86–
89). Integrins are critical, as they are receptors located on the surface of host cells
that facilitate interaction with components of the ECM, and by binding fibronectin,
allow cells to remain adherent and migrate effectively (90–92). All of the
extracellular proteins listed above are potential targets for bacteria—such as B.
burgdorferi—attempting to transverse the infected host during the course of a
systemic infection.

ECM proteins in bacterial infections
One of the first stages in any bacterial infection is the organism’s adherence
to host tissues (93). The host factors that facilitate these processes are numerous,
but one apparent target is the host ECM. With the ability to alter signaling, as well
as facilitate adhesion and migration, the varied functions of the ECM align perfectly
with the goals of a bacterial invader. The most common molecules that bacteria use
to adhere to host cells are bacterial surface-exposed proteins (94). Often, these
bacterial proteins can recognize and bind several targets, thereby enhancing their
efficiency and purpose (95–97). Collagens, the most abundant protein type in the
body, are recognized by a variety of bacteria, particularly collagen V (98–101),
which, while a relatively minor proportion of total ECM collagen, is the collagen type
most closely associated with the surface of cells and aids in Collagen type I
organization (102, 103). The other major component of the interstitial matrix,
GAGs, are bound by many different bacteria as well, including those that affect the
respiratory, GI, neural, and reproductive systems (104–106).
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As a bridging molecule, Fn is a prime target for bacterial invaders. Numerous
bacterial pathogens recognize and bind Fn, a process that is often essential for the
virulence of the organism (107). Some bacterial proteins preferentially bind the
soluble form of Fn, while other proteins have a higher affinity for insoluble Fn (108).
In accordance with its variety of functions under normal physiological conditions,
Fn has also been characterized as having the potential for multiple uses by its
bacterial hijackers. One potential use is that the coating of the bacterium by a
dynamic host molecule may help alter the immune response against the infection
(109, 110). Another use for Fn appears to be attachment to Fn on the surface of host
cells (100, 111, 112). Treponema pallidum has an Fn-binding protein, TP0483, that
interferes with the ability of host cells to bind to Fn by interacting with the cell
binding domain (108). This may serve the function of causing cell layers to become
less adherent, and facilitate the bacterium’s movement across those normally
impassible barriers. Still other bacteria, such as Staphylococcus aureus, take
advantage of Fn’s cell-binding ability to allow the bacterium to internalize into host
cells (113, 114). Indeed, of 163 tested clinical isolates of S. aureus, all of the tested
strains produced at least one Fn-binding protein (115). In an S. aureus infection, the
bacterium is taken up into non-professionally phagocytic cells (i.e. cells that are not
immune cells). This may allow the bacterium to evade potential immune responses
and increase its overall virulence (116). Many bacteria encode multiple Fn-binding
proteins in their genome, although it is not always known whether these proteins
are truly redundant, or if they may enable a bacterium to use Fn in multiple ways by
taking advantage of the diversity in potential binding sites present in Fn.
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All of the aforementioned ECM proteins have B. burgdorferi binding partners.
The spirochete is able to bind collagen (98), decorin (117, 118), GAGs (119), and
fibronectin (120–123) as well as many other ECM components too numerous to list
here, as has been reviewed previously (124). As with other bacteria, B. burgdorferi
encodes many proteins that can interact with the same partners. At present, there
are at least 5 proteins encoded by the bacterium that are able to interact with Fn.
Additionally, more spirochete proteins are likely to be identified as Fn-binders in
the near future. The most well studied Fn-binding protein was also the first
discovered, BBK32 (122). BBK32 was first discovered in 1998, and many of the
mechanisms regarding BBK32-Fn interactions have been characterized, including
the locations of the binding regions, and the biochemical mechanisms of binding
(123, 125). While BBK32 has been demonstrated to have a role in infection (126),
other groups have found no detectable role for the protein in an infection process
(127), further highlighting the difficulty of studying these proteins in a Lyme
infection. This difficulty is compounded by the presence of the other Fn-binding
proteins including RevA/B, CRASP-1, and BB0347 (120, 121, 124, 128). In addition
to this, BBK32 and CRASP-1 have also been characterized as interacting with other
proteins (GAGs and factor H, respectively), making the specific, targeted study of Fn
interactions by the proteins problematic at best. Furthermore, it remains possible
that the RevA/B proteins and BB0347 also have other binding partners that have
yet to be characterized.
The role for the Fn binding of each protein is also difficult to discern. B.
burgdorferi that are BBK32 deletion mutants display altered migration through
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infected hosts (129), and adding BBK32 to a non-infectious B. burgdorferi strain
increases the bacterium’s ability to adhere to host blood vessel endothelial cells
(130). The defect in infectivity, however, disappears at later timepoints of infection.
Additionally, we have found that RevA, while also not necessary for a B. burgdorferi
infection, enhances tissue burden and attenuates the host immune response in vivo
(131). In vitro results have also suggested that bacteria expressing RevA are less
immunostimulatory when co-cultured with macrophages (unpublished data). This
may suggest that RevA may use the Fn as a cloak to disguise itself from host immune
cells, thereby facilitating the increase in infectivity seen in our published studies.
Indeed, proteolytic fragments of Fn only formed during pathogenic or abnormal
conditions are known to be immunostimulatory, and the sequestration of these
degradation byproducts may serve to ameliorate the host immune response (132).
One of the least studied Fn-binding proteins in B. burgdorferi is BB0347.
Previous studies have found that BB0347 binds Fn, but doesn't have a detectable
role in vascular escape (130), and that over expressing BB0347 in a non-infectious
strain aids in bacterial survival in joint blood vessels (133). More work needs to be
performed to determine the specific roles of these multiple Fn-binding proteins in a
B. burgdorferi infection, and whether the functions of the proteins overlap or if the
various proteins indeed have separate and/or complementary roles.

Other B. burgdorferi physiology
One of the most striking characteristics of B. burgdorferi is the mechanisms it
has evolved to avoid provoking a host response. As mentioned previously the
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membranes of B. burgdorferi do not contain the classic Gram-negative bacterial
hallmark LPS (47). Additionally, the bacterium encodes no known classic toxins
(134). A toxin in bacteriology is a compound that is secreted from the bacterial cell
with the function of altering the function or metabolism of another target cells.
Targets for toxins include other bacteria or host cells and can be anything from the
host membranes to necessary enzymes in the host. An example of a classic toxin
would be botulinum neurotoxin from Clostridium botulinum, which is internalized
into host nerve cells and cleaves SNARE proteins, preventing release of
neurotransmitters to induce paralysis in infected hosts (135). Lyme borreliae have
no such proteins that have yet been identified, and such molecules could potentially
be detrimental to the overall bacterial goals, which require survival of the hosts for
as long as possible to allow for vector transmission. While other bacteria may cause
death of the host to further the bacterial life cycle (such as with C. botulinum, which
typically resides in soil), B. burgdorferi, on the other hand, is completely non-viable
outside of its niche hosts or the artificial growth medium of the laboratory (23). In
fact, the genome of B. burgdorferi is highly reduced, consisting of a 1million basepair linear chromosome (itself a rarity in the bacterial kingdom) with up to twenty
extra-chromosomal elements both linear and circular (36).
The life cycle of Lyme borreliae also lends itself to a minimally
immunoreactive modus operendi. In fact, the natural reservoir of the bacterium in
the wild, does not present with inflammation (136). As mentioned, the bacterium is
maintained in nature via a mammal to tick to mammal route of infection (or, with
some Lyme species, birds to ticks to birds). The tick life cycle can take years, which
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necessitates the bacterium surviving in both the tick and infected mammal/bird
vectors, often for long periods of time. These infected hosts would not be able to
survive for long periods in the wild, thereby propagating the bacterium, if they
developed deleterious symptoms during a borrelial infection. Animals that develop
symptoms during a B. burgdorferi infection (including humans) are referred to as
“dead-end hosts,” and are not typically involved in the transmission of the
bacterium (23). What constitutes a dead-end host even depends on species and
strain variation of the Lyme Borrelia, as some are adapted to prefer some types of
animals to others, often co-evolving with the tick vector for specific animal
preference (137). As no known toxins are present in B. burgdorferi, and the
pathogen never achieves particularly high densities in the tissues of infected
organisms (138), the bulk of disease states that we see in hosts is the result of an
immune reaction to the pathogen (139, 140). Borreliae themselves have few factors
facilitating this response (141), other than the aforementioned TLR2 ligands,
lipoproteins.
Lipoproteins in Gram-negative bacteria typically reside in the periplasmic
space between the inner and outer membranes (142). The classic example of a
lipoprotein, Lpp, from Escherichia coli, anchors the periplasmic peptidoglycan layer
to the outer membrane, stabilizing the membrane by doing so (143). However,
spirochetes including B. burgdorferi, often present their lipoproteins on the
extracellular surface of the bacterium (144, 145). This enables the bacterium to
interact with host components such as those in the ECM via specific lipoproteins.
Indeed, many of the ECM-binding proteins described previously are surface exposed
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lipoproteins. Another family of lipoproteins whose function remains to be
characterized is the major lipoprotein family (Mlp) (146–149). These proteins are
encoded on the plasmids of B. burgdorferi, thus their presence is strain-specific, with
many strains of B. burgdorferi lacking one or more of the Mlp family members. One
member of this family, MlpJ, is homologous to a protein from the European Lyme
spirochete, B. afzelii, which has been characterized as a Congo red and heminbinding protein (150).

Hemin and iron in bacterial infections
In animals, iron is almost never found as a free-floating ion (151, 152).
Instead, iron is most often bound in complexes known as protoporphorin rings such
as hemin (153). These molecules are, in turn, bound in protein complexes such as
hemoglobin. Iron performs important roles in metabolism of the host, functioning
as an important cofactor in energy production, oxygen circulation, radical
detoxification, and proteolysis (154–156). Bacteria, in turn use host iron to
facilitate growth, and nearly all bacteria require iron for survival (152). In fact,
many bacteria use the absence of iron as a signal that they have entered the
mammalian host environment, and to adjust expression of pathogenicity genes
accordingly. In turn, bacteria have evolved a number of strategies to facilitate
acquisition of this highly sequestered host iron. Siderophores, small iron-chelating
compounds with very high affinities are one of the most common mechanisms of
iron acquisition in bacteria (157, 158). Some bacteria also have proteins that will
directly bind to hemin and hemin-containing proteins to facilitate iron uptake of
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these complexes, where they can they later strip the iron from the hemin ring (159–
162). It is important to note that many of these proteins are located intracellularly,
in fact only about 0.1% of normal physiological iron, bound by transferrins, is
located extracellularly. Consequently, acquisition of iron can be immunogenic, as
host cells are lysed to facilitate the release of their iron-containing proteins into the
extracellular milieu, where the iron can be accessed by extracellular bacteria or
fungi (163, 164).
B. burgdorferi avoids this problem altogether, as it is the only known
mammalian pathogen with no metabolic need for iron (165). In fact, the
intracellular concentration of iron in B. burgdorferi is approximately 5 atoms per
cell, a physiologically insignificant number. Additionally, adding iron chelators to
the bacterium’s growth medium has no effect on B. burgdorferi replication and
growth. A number of important proteins in the bacterium use other metals in the
place of iron (166), and B. burgdorferi also has evolved to survive without an
electron transport system (166, 167), a usually necessary and iron-dependent
source of cellular energy. All of these adaptations may be the result of the
bacterium avoiding provoking an immune response whenever possible, and have
allowed the bacterium to survive long term in infected hosts.
Even though B. burgdorferi has adapted to an iron-free lifestyle, the
bacterium still encodes for proteins that will bind to iron (168, 169). In fact, the
bacterium will increase the amount of iron bound to the outer membrane in the
absence of manganese ions (Mn2+). It is known that Mn2+ is a regulator of the
previously described RpoN/RpoS transcription factor cascade, and low intracellular
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Mn2+ concentrations will induce a response mimicking that of a mammalian host in
B. burgdorferi (170). Deleting the transporter responsible for Mn uptake in the
spirochete causes a massive increase in iron binding to the surface of the bacterium,
suggesting that this binding to iron is regulated, and is induced by the bacterium
when it senses that it is in the mammalian environment (as opposed to that of the
Ixodes tick vector) (168). As a potentially surface-exposed lipoprotein expressed
during a mammalian infection that is homologous to a known hemin-binding
protein, MlpJ may function as the mediator for this surface iron binding.

Proposed Studies
The overall goal of the Brissette laboratory is to determine the factors
promoting virulence in a Lyme disease model. Toward this end, we propose herein
to determine the roles of two functionally diverse proteins that we have previously
described, BB0347 and MlpJ. These proteins remain understudied and may
potentially contribute significant functions in B. burgdorferi lifestyle and
pathogenesis. In the proceeding studies, we aim to determine, first, if both BB0347
and MlpJ are surface exposed. We also intend to identify whether each protein will
interact with the targets proposed during this introduction; fibronectin and hemin,
respectively. The mechanisms facilitating the interactions of proteins can also be
used to determine a great deal about protein dynamics and possible therapeutic
targets in future studies. Additionally, determining the role of each protein in a
mammalian infection may yield important information regarding the pathogenesis
of B. burgdorferi and direct the formation of future studies. By characterizing
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proteins important in the maintenance and progression of a Lyme infection, we may
be able to determine factors promoting the symptoms and progression of the
associated disease. This includes the apparent persistence of symptoms in some
patients even after antibiotic treatment.
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CHAPTER II
SURFACE EXPOSURE OF BB0347 AND MLPJ
Rationale
Both of the proposed proteins, BB0347 and MlpJ, are speculated to interact
with components of the ECM. In order for these proteins to adequately perform this
function in intact bacteria, they must be presented on the outer surface of the
bacterium. MlpJ has a classic lipobox domain that suggests the protein is located on
the outer membrane (146), but this remains to be proven experimentally. Even if
MlpJ is anchored to the outer membrane, the protein may orient inwards towards
the periplasmic space, as this is the classic lipoprotein orientation. BB0347,
meanwhile, has no predicted lipobox near its published translational start site, and
also has no predicted transmembrane domains. Multiple other proteins in B.
burgdorferi and other spirochetes have been established as surface localized by
several techniques, including surface proteolysis and immunofluorescence
microscopy (171, 172).
Another phenomenon that would serve as an impediment to these proteins’
functions would be the lack of transcription of their genes. Many DNA sequences—
known as “pseudogenes”—are annotated in bacteria as being genes, but they are not
actually actively transcribed (173–176). Although MlpJ expression by B. burgdorferi
has been verified previously, the question remains as to whether BB0347 is, in fact,
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an expressed gene. Additionally, if BB0347 is expressed at all, the role for its
putative Fn-binding capabilities is unknown. One of the first investigations that will
potentially demonstrate whether BB0347 aids in spirochete binding to Fn in
infected mammals is whether the protein is expressed in mammals at all. The dualhost lifestyle of B. burgdorferi results in populations of spirochetal proteins that are
highly regulated to specific host types (23). One method to determine if the protein
is expressed during a mammalian infection is to check whether hosts infected with
the bacterium produce antibodies against that protein (146). By analyzing the subcellular locations and expression profiles of our proteins of interest, we can begin to
characterize their importance during a mammalian infection.
Table 2-1) Primers used in Chapter II.
Name

Sequence 5’-3’

Function

BB0347protF

CACCATGATAAAAATGTCTTTGAATTACACTG

Cloning of BB0347 into pET200

BB0347protR

TTAGGTTTGATTTTTTATTTTTTTTATTAG

OspCprotF

CACCTGTAATAATTCAGGGAAAG

OspCprotR

TTAAGGTTTTTTTGGACTTTCTG

FlaBprotF

CACCATTATCAATCATAATACATCAGCTA

FlaBprotR

TTATCTAAGCAATGACAATGACAAAACATATTGG

MlpJprotF

CACCATATCTTTGCTACTACTAAATAGCTGTAAT

MlpJProtR

TTAGTTTTGCCAATTAGCTGTAAGACC

Fla3*

GGGTCTCAAGCGTCTTGG

Fla4*

GAACCGGTGCAGCCTGAG

CAB105

ACATTGAAAACGAAAAGGAA

CAB106

AAAGAATTTTTGCCCTTTTT

Cloning of OspC into pET200
Cloning of FlaB into pET200
Cloning of MlpJ into
pET200
Amplification of flaB for
RT-PCR
Amplification of bb0347
for RT-PCR

*primers were described previously (177)
Materials and Methods
Animals and ethics statement
The protocol for animal infection was approved by the University of North
Dakota Institutional Animal Care and Use Committee (IACUC protocol #1101-2), in
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accordance with Association for Assessment and Accreditation of Laboratory
Animal Care guidelines (Animal Welfare Assurance: A3917-01). Mice used for this
study were 4 to 6 week-old female C3H/HeNHsd or Balb/C (Harlan; Madison, WI),
and were cared for under the guidelines of the National Research Council of the
National Academics Guide for the Care and Use of Laboratory Animals (8th Edition).
All efforts were made to minimize animal suffering.

Bacteria and culture conditions
Borrelia burgdorferi strain MI-16, an infectious clone of the sequenced type
strain that contains all parental plasmids (167, 178), was used at low passage levels
for all experiments described in this section. The spirochetes were grown in
modified Barbour-Stoenner-Kelly (BSK II) medium (179) supplemented with 6%
rabbit serum (Pel-Freeze, #A00274; Rogers, AR) at 23 or 34oC to cell densities of
approximately 5 × 107 cells/mL except where otherwise noted. Additionally, One
Shot TOP10 Escherichia coli (Life Technologies, #C4040-06; Grand Island, NY) and
chloramphenicol-resistant Rosetta(DE3)pLysS E. coli (Novagen, #71401-4; Madison,
WI) strains were used in cloning and production of recombinant proteins,
respectively, and were grown in LB broth or agar plates, unless otherwise noted.

Antibody production
Anti-BB0347, OspC, and FlaB antibodies were produced by Proteintech using
recombinant proteins produced in our laboratory (protocol to follow). Antibodies
against MlpJ were produced by infecting Balb/C mice with 200µg of MlpJ in a 1:1
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mixture of alhydrogel (Invivogen, # vac-alu-250; San Diego, CA) once every two
weeks for a total of four injections. Mice were sacrificed by incubation in C02
followed by cervical dislocation one week after their final injection, and blood was
collected into heparin-coated tubes after decapitation of the killed animals. The
collected blood was then spun at 6000 relative centrifugal force (rcf) for 10 minutes
to separate plasma from blood cells. Plasma was saved, aliquoted for single use, and
stored at -20oC

Recombinant Protein Production
DNA sequences were amplified via PCR using DeepVent DNA Polymerase (NEB,
#M0258S; Ipswich, MA). Primers used for amplification are listed in Table 2-1. The
nucleotide sequences were then cloned into the pET200 expression vector (Life
Technologies, #K200-01), transformed into TOP10 E. coli, and cells were plated on
LB agar supplemented with kanamycin (50μg/mL). Resulting colonies were
screened by colony PCR (180) for the appropriately sized insert and further verified
by bidirectional sequencing of purified plasmid DNA (Davis Sequencing; Davis,
CA/Eton Biosciences; San Diego, CA).
To produce proteins, plasmids with appropriately inserted coding regions
were transformed into Rosetta(DE3)pLysS (Invivogen) and plated on LB agar with
kanamycin (50µg/mL) and chloramphenicol (30µg/mL—Sigma, #C-0378).
Individual colonies were selected and inoculated into either super broth (SB—32 g
Tryptone, 20 g yeast extract, 10 g NaCl, per liter of H2O) starter culture or Dual
Media Set (Zymo, #M3011; Irvine, CA) Expansion broth (EB) overnight, both
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supplemented with kanamycin and chloramphenicol as above. SB starter culture
was transferred (≤1:50 dilution) into final cultures of antibiotic-supplemented SB
and allowed to grow to an OD ~0.5, then induced with 0.1-0.3 mM final
concentration isopropyl β-D-1-thiogalactopyranoside (IPTG) for four hours. EB was
transferred to antibiotic-supplemented Dual Media Set Overexpression Broth and
allowed to grow overnight at 37oC with shaking at approximately 200 rpm. From
both media, the cells were spun down, re-suspended in MagneHis wash buffer
(MHWB-100mM HEPES, 10mM imidazole), and lysed via sonication with a Model
705 Sonic Dismembrator (Fisher Scientific; Pittsburg, PA). The recombinant
proteins were purified with Nickel bead affinity chromatography using MagneHis
Ni-Particles (Promega, #V8565; Madison, WI) and magnetic stands. Four washes
using MHWB were used to remove contaminating proteins, and MagneHis elution
buffer (100mM HEPES, 500mM imidazole) was used to elute the purified
recombinant proteins from the Nickel particles. This final elution buffer was
replaced with phosphate buffered saline via dialysis in 3,500 MWCO dialysis
cartridges (Pierce, #66330; Rockford, IL). Final protein concentrations were
determined by a BCA assay (Pierce, #23227) and purities were assessed by SDSPAGE followed by staining with Coomassie brilliant blue dye.

Protease Protection Assay for BB0347
Spirochetes were grown in culture until optimum production of BB0347 was
observed (late log-stationary phase). Cells were then harvested by centrifugation at
4000 × g for 20 minutes and washed once with PBS supplemented with 10mM
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MgCl2 to remove media components; then centrifuged again. Bacteria were counted
and re-suspended in the same buffer at a density of 2 × 109 cells/ml. These bacteria
were treated for various times with PBS (as a negative control), proteinase K (40
µg/mL), pronase (0.05 µg/mL), and trypsin (40 µg/mL) at 34oC. The reactions were
stopped via the addition of EDTA (1.0 mM final—pronase only), PMSF (Sigma,
#93482) (800 µM—all), and Pefabloc SC (Roche, #11585916001) (0.25 mg/mL—
pronase and trypsin), and subsequent incubation on ice for 10 min. After this time,
the cells were spun down and re-suspended in SDS-PAGE Sample loading buffer and
boiled for 10 minutes to lyse the cells. Protein levels were determined with
polyclonal rabbit antibodies against BB0347, FlaB (negative control), and OspC
(positive control) as follows. The separate protease treatments were separated on
several 12.5% SDS-PAGE gels (one for each probed protein), and each was
transferred to a nitrocellulose membrane. Membranes were blocked overnight in a
solution of 5% nonfat dried milk (NFDM) in tris-buffered saline (50mM Tris-Cl,
150mM NaCl, pH: 7.5), the next day, the membranes were washed with TBS plus
0.05% tween (TBST) and probed with the primary antibodies (1:25,000 FlaB,
1:10,000 OspC, and 1:1000 BB0347 all in TBST). Subsequently, the membranes
were washed again and probed with Goat αRabbit-IgG antibodies conjugated to
horseradish peroxidase (Pierce, #31460) at a dilution of 1:14,000 in TBST. Finally,
the membranes were extensively washed with TBST, and incubated in
SuperSignalWest Pico chemiluminescent substrate (Thermo, #34080).
Luminescence was read with via a Biochemi cooled camera and Epichemi3
darkroom with LabWorks 4.5 software (UVP; Upland, CA).
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Protease Protection assay for MlpJ
B. burgdorferi were grown to mid-log phase, centrifuged, and washed as
above. To treat the cells, Proteinase K at 4 mg/mL (a higher concentration than that
used to assay BB0347) was added for 30 min at 24oC (room temperature), and the
reaction was stopped by the addition of PMSF to a final concentration of 50 µg/mL
as above. Bacteria were processed for Western blotting using the same conditions
and controls as detailed above, except that MlpJ was detected by the suspension of
the membrane in a dilution of mouse serum from MlpJ-inoculated mice at 1:500 in
TBS-T plus 5% non-fat dry milk for 1 hour at room temperature. To detect anti-MlpJ
a mixture of anti-mouse IgG and IgM (1:5000 each in TBST) was added to the
membrane for 1 hour. Both OspC and FlaB (used again as controls) were probed for
as above. Other steps and reagents were used as described above, except that
luminescence was measured with a LI-COR Odyssey Fc imaging system (LI-COR;
Lincoln, NE)

Immunofluorescence Microscopy
Bacteria were grown and centrifuged as in the protease protection assay
protocol, except that two washes were performed in non-supplemented PBS.
Bacteria were concentrated 50-fold in the final suspension, into which slides were
placed for 15 min at room temperature to allow for adherence of spirochetes.
Without allowing time for drying, the bacteria were fixed to the slide with a 10%
formalin solution (Ricca Chemical, #3190-5; Arlington, TX) for 15 minutes. To
confirm effectiveness of our αFlaB antibody, some spirochete membranes were
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disrupted by desiccation prior to formalin fixation. After treatment, the bacteria
were washed 3 times with PBS and then blocked with 1.0% BSA in PBS overnight at
4oC with gentle agitation. The following day, the slides were washed again with PBS,
and treated with affinity-purified antibodies against FlaB (1:1000 dilution in PBS),
OspC (1:500), or BB0347 (1:50) for two hours at room temperature, followed by a
1.5-hour incubation with anti-rabbit IgG conjugated to Dylight 488 (KPL, #072-0315-06; Gaithersburg, Maryland). Slides were then mounted with Vectashield
mounting medium supplemented with 4',6-diamidino-2-phenylindole (DAPI)
(Vector, #H-1200; Burlingame, CA). Microscopy was carried out on an Olympus
BX51 microscope with a DP71 Camera and Cellsens standard viewing software
(Olympus; Center Valley, PA).

Verification of BB0347 transcription
Spirochetes were grown as described above, and RNA was extracted using
TRIZOL reagent (Thermo Fisher, #15596018; Waltham, MA) as per the
manufacturer’s instructions, and DNA was removed from the sample using the
Turbo DNA Free kit (Thermo Fisher, #AM1907). cDNA was created using the
SuperScript III reverse transcriptase kit (Thermo Fisher, #18080044 ). Primers
used to amplify the bb0347 and flaB genes are included in Table 2-1, the target
genes were amplified using Takara rTaq (Clonetech, #R001A; Mountain View, CA)
cycler conditions were as follows: 94°C-1 min; 35 cycles of 94°C-30 seconds, 55°C30 seconds, 68°C-30 seconds; 68°C-7 min. Products were run on a 1% agarose gel,
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stained with ethidium bromide for 15 minutes, and images were captured with a UV
transilluminator with an exposure time adjusted to the individual gel.

Overlap PCR
To generate an N-terminal truncation of rBB0347, an overlap PCR was
performed with the primers listed in Table 3-1. The Expand High Fidelity PCR
system (Roche, #11732641001; Indianapolis, IN) was used with the following
thermal cycler protocols: 94°C-3 min; (94°C-30 sec, 50°C-30 sec, 67°C-6 min)×10;
(94°C-30 sec, 50°C-30 sec, 67°C-6 min with Δ15 sec each cycle)×25; and a final
extension of 7 min at 67°C. Following the PCR, the product was run on an agarose
gel and purified with a Qiaquick gel extraction kit (Qiagen, #28704; Valencia, CA).
Following purification, the DNA was digested with DpnI (NEB, R0176S) overnight at
a concentration of 400 U/mL to ensure that no parent DNA remained, after which
point, plasmid was transformed into One Shot TOP10 E. coli as above. All other steps
for verification and protein production were performed as detailed above.

Immunogenicity of BB0347
Mice were infected by needle inoculation with 106 cells of B. burgdorferi MI16. Sera were harvested from the mice pre-inoculation and eight weeks postinoculation. Purified rBB0347ΔN53 was run on an SDS-PAGE gel and transferred to
a nitrocellulose membrane, and a Western blot was performed using a 1:500
dilution of the harvested serum as the source of primary antibodies. αMouse-IgG
(GE Healthcare, #NA931; Waukesha, WI) was used to detect any native αBB0347

27

antibodies from the infected mice, and substrate was used as described above. As a
control, the purified αBB0347 affinity purified antibodies were used, and these were
recognized with Goat αRabbit-IgG as previously used in the protease protection
assays.
Statistics
All figures shown in this chapter are representative of at least three
independent experiments with similar results. No other statistical analyses were
performed in the studies detailed in this chapter.

Figure 2-1) BB0347 is expressed and produced in culture. A) Expression of
BB0347 was verified by RT- PCR with flaB mRNA as a control. Lane 1: flaB from
genomic DNA, lane 2: flaB from cDNA, lane 3: no template control, lane 4: bb0347
from genomic DNA, lane 5: bb0347 from cDNA, lane 6: no template control, L: ladder.
B) Western blotting shows that BB0347 protein is produced in the spirochete over
the course of growth in BSKII culture medium.
Results
bb0347 is transcribed and its protein is produced during infection
Although bb0347 is annotated as an Fn-binding protein, prior to our studies,
it had not yet been confirmed to be expressed. To clarify, often DNA segments can
appear to be genes, but are not used for transcription or translation, i.e. not serving
as a coding template. Such sequences are known as pseudogenes. To verify the
bb0347 is expressed, we performed reverse transcriptase PCR using primers
specific to bb0347 (Table 2-1), and used flaB as a control (Fig. 2-1A). We further
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verified the effectiveness of the bb0347 gene by confirming that the mRNA is
translated by probing for the protein product via the use of antibodies specific to
BB0347 (Fig. 2-1B). During the studies, we also examined the time course of
BB0347 and found relatively consistent production of the protein under normal
culture conditions (34°C, microaerobic). Having determined that bb0347 is
expressed and results in a detectable gene product, we sought to further understand
the subcellular localization of the produced protein.

BB0347

Figure 2-2) BB0347 is vulnerable to proteolysis in intact spirochetes. B.
burgdorferi were treated with the following proteases: Proteinase K (K), Pronase (P)
and Trypsin (T). An additional group of spirochetes were left in medium untreated
by proteases. A decrease in band intensity relative to control indicates digestion of
the probed protein by the protease. Proteins tested were FlaB (negative control),
OspC (positive control), and BB0347.
Protease protection assay and immunofluorescence of BB0347
A preliminary Triton X-114 solubility assessment suggested that BB0347 was
associated with the membranous portion of B. burgdorferi (data not shown).
However, this protocol did not allow for exact subcellular localization BB0347 (i.e.
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Figure 2-3) BB0347 is available to antibodies in intact B. burgdorferi. Bacteria
were stained with antibodies against OspC (top left), BB0347 (top right), and FlaB
(bottom panels). In the bottom right panel, bacteria were desiccated to allow for
permeabilization of the outer membrane as a control verifying in situ efficiency of
the FlaB antibodies generated during the course of these studies. The white scale
bars indicate a distance of 10 microns.
the inner or outer membrane) or its orientation within that membrane. To
differentiate between surface exposed and membrane-associated but intracellular
proteins, we performed a protease protection assay. FlaB was used as a loading and
protease-resistant control because, in spirochetes, the flagella are located between
the inner and outer membranes (181), and degradation of FlaB would indicate that
the outer membrane had been compromised, thereby nullifying the results of the
test. The proteases used were able to digest BB0347 and OspC—a well-established
borrelial surface marker—almost completely after two hours, while FlaB levels
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remained constant in all of the two-hour lanes (Fig. 2-2). These data suggest that
BB0347 is located on the outer membrane of the gram-negative B. burgdorferi
spirochete.
Previous work performed on BB0347 found that the BB0347 tested was
resistant to treatment by proteases (130). We therefore, sought to verify our results
seen with the protease protection assay by using immunofluorescence microscopy
(Fig. 2-3). This technique has also been used previously to verify the outermembrane localization of proteins in spirochetes as well as other microbes. We
found that B. burgdorferi presented heterogeneous expression of both OspC (12.1%
of spirochetes were positive for OspC fluorescence) and BB0347 (8.9%). This is
consistent with other published reports suggesting that only approximately 10% of
a given population of B. burgdorferi from culture conditions produce detectable
levels of OspC protein (182, 183).
Furthermore, more intense fluorescence emanated from the αOspC stained
spirochetes. This correlates with the relative band intensity of the two proteins in
the protease protection assay Western blots (αOspC lanes were exposed for 20 sec,
while αBB0347 were exposed for 100 sec). αFlaB antibodies were again used as a
negative control to ensure that the spirochetal outer membrane were intact, and, as
expected, αFlaB produced no spirochete-specific staining in intact B. burgdorferi. To
ensure that the lack of staining observed in the αFlaB samples was due to
membrane impermeability and was not the result of poor antigen recognition of
αFlaB in situ, we also included, as a control, spirochetes whose membranes were
disrupted, then stained with αFlaB. These spirochetes all were shown to fluoresce,
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verifying that the αFlaB antibodies were effective. Therefore, the BB0347 was
detected by immunofluorescence because it is surface exposed in intact spirochetes
and not because of membrane-barrier subversion. Additionally, the percentage of
OspC and BB0347-positive spirochetes did not increase upon membrane disruption
(data not shown), further supporting the hypothesis that BB0347 is entirely surface
localized in B. burgdorferi MI-16.

Figure 2-4) MlpJ is surface exposed. A protease protection was performed as for
BB0347 (see materials and methods for differences), except that antibodies against
MlpJ were used as the test group. Controls used were those utilized previously.
Protease protection assay of MlpJ
The primary sequence of the MlpJ protein suggests that it has a lipobox, a
sequence targeting it for the outer membrane along with a cysteine residue that is
palmytolated, anchoring an otherwise soluble protein in the hydrophobic lipid
membrane. Lipoproteins, while traditionally located periplasmically in most
bacteria, are often found on the extracellular surface of B. burgdorferi. To determine
whether MlpJ is exposed on the surface of the bacterium, we performed a protease
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protection assay similar to that use for BB0347 (Fig. 2-4). Namely, only one
protease was employed (proteinase K), and data were collected for only one time
point (30 minutes). Nevertheless, we observed complete degradation of MlpJ in the
protease-treated samples, thereby confirming that MlpJ is surface exposed.

Figure 2-5) BB0347 is produced by B. burgdorferi during a mammalian
infection. Serum from uninfected mice (lane 1) and mice infected for one month
with B. burgdorferi were tested for their ability to interact with recombinant
BB0347. As a control, purified anti-BB0347 antibodies from rabbit serum (lane 3)
were also analyzed. Lanes 1 and 2 were post-stained with anti-mouse IgG and lane
3 was treated with anti-rabbit IgG secondary antibodies conjugated to HRP.

Detecting antibodies against BB0347 during a mammalian infection
The fact that B. burgdorferi produces BB0347 and MlpJ in culture (Fig. 2-1) is
not strictly indicative that the proteins are also produced during infection of a
mammalian or tick vector. The expression of MlpJ during an infection has already
been verified experimentally. Researchers were able to characterize the promoter
region of the gene as well as determine that mice infected with B. burgdorferi B31
produced antibodies against MlpJ, suggesting that it the protein is produced during
a murine infection (146).
To verify that BB0347 is also produced when the spirochete has infected a
mammal, we performed a similar experiment searching for antibodies produced
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against BB0347. We were already confident that BB0347 could be used as an
antigen, as we were able to obtain antibodies when rabbits were infected with
purified protein (see materials and methods, this chapter), and these antibodies
were able to bind to denatured (Fig. 2-2) as well as native proteins (Fig. 2-3). We
found that mice infected with live B. burgdorferi, but not naïve mice, produced
antibodies against purified recombinant BB0347, verifying the production of
BB0347 during a mammalian infection (Fig. 2-4).

Discussion
These studies were the first to confirm that both BB0347 and MlpJ are
surface exposed in intact B. burgdorferi spirochetes. Furthermore, no studies before
these had confirmed the expression of the bb0347 gene and the production of the
resulting protein product in a wild-type bacterium, although other studies have
been performed overexpressing the gene in non-infectious strains (130, 133). As
both products are hypothesized to interact with components of the extracellular
matrix, the outer surface of the bacterium is the ideal location for their presentation.
These proteins may play important roles in the survival processes of B. burgdorferi.
Many virulence factors have been characterized in B. burgdorferi, and many of these
are surface-anchored proteins (117, 119, 126, 129, 131). As the bacterium lacks any
as-yet characterized secreted toxins, it may depend on surface–bound ECM products
to facilitate its movement and even potentially activate host pathways promoting
virulence (184). Surface-exposed proteins may play also play a role in disease
progression and treatment outcomes. For instance, in post-treatment Lyme disease
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syndrome, patient symptoms can persist for an extended period of time. The
delayed clearance of bacterial debris by the host immune system may be an
important factor driving this phenomenon, which in turn may be facilitated by
interaction of bacterial proteins with the ECM (185). Perhaps these interactions
may shield bacterial debris from sentinel cells, postponing detection. Alternatively,
proteins from B. burgdorferi may localize the bacterium (or dead bacterial debris) to
sites that are not normally accessed by immune cells—again preventing detection.
This is not to say that the only proteins of importance are those located
extracellularly. There may be a role for internalized proteins that interact with the
ECM as well. When bacteria are lysed (such as after antibiotic treatment),
intracellular proteins may be released that facilitate ECM interactions previously
not possible when the bacteria were alive, serving as a potential explanation for the
amber theory in which killed bacteria continue to stimulate an immune reaction
(185). Additionally, released intracellular proteins may help other bacteria
unaffected by treatments or immune reactions escape by serving as a decoy for host
immune factors. In fact, we have found that antibiotic-killed bacteria are more
highly immunostimulatory in vitro, and B. burgdorferi highly disturbed by sonication
initiate an even stronger response (unpublished data). The antibiotic-killed
bacteria, when viewed under a microscope, are seen to have substantial membrane
blebbing, suggesting a destabilization of the cellular membranes and leakage of
intracellular contents. Indeed, more work is needed to characterize the differences
in host response to live vs. dead bacteria and which proteins or other factors drive
these observed phenomena. Lastly, not all proteins are localized exclusively to a
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specific subcellular compartment. For example, enolase in B. burgdorferi was found
to exist as both a periplasmic and extracellular protein (172, 186), and a similar
phenomenon was seen with the enolase of another spirochete, Leptospira
interrogans. These multi-function or multi-location proteins are known as
moonlighting proteins, and are of increasing interest to bacterial researchers (187).
However, the finding that BB0347 and MlpJ are both surface exposed
suggests that they may be important in the life cycle of live spirochetes during
normal conditions, either during tick colonization and persistence, or in the
establishment/maintenance of a mammalian host infection. To test whether this is
the case, we next analyzed the interactions of BB0347 and MlpJ with their proposed
substrates with in vitro experiments—Chapters III and IV, respectively—and the
proteins’ roles in a mammalian infection—Chapter V.
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CHAPTER III
IN VITRO CHARACTERIZATION OF BB0347-FN INTERACTIONS

Rationale
In the previous chapter we revealed that BB0347 is located on the outer
surface of B. burgdorferi under culture conditions. However, the functionality of the
protein had yet to be verified. Although BB0347 is annotated as an Fn-binding
protein, no studies prior to ours had verified that BB0347 interacts with Fn.
Additionally, if BB0347 does bind to Fn, the mechanisms facilitating this interaction
remain unknown. As detailed in Chapter I, Fn is a highly complex and diversified
protein with a number of potential binding sites, each with the potential for unique
sequences facilitating interaction (83). Elucidating the domains of Fn bound by
BB0347 may be important, as determining which region(s) of Fn interact with the
spirochete protein could help in establishing a role for BB0347 in a host infection.
For instance, TP0483, an Fn-binding protein from Treponema pallidum, interferes
with the ability of Fn to act as a bridge between host cell integrins and Fn by
blocking the RGD sequence of the host glycoprotein (108). Conversely, when FnBPA
from Staphylococcus aureus binds to Fn, it does so in such a way that to make the
RGD sequence accessible to α5β1 integrins (107, 113, 188). This facilitates uptake of
S. aureus into host cells and enhances bacterial virulence. Interestingly, β1 integrins
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have also been implicated as potentially necessary for bacterial endocytosis in a B.
burgdorferi infection (189).
A reports have shown that B. burgdorferi, like S. aureus, is able to be
internalized into host cells not normally involved in pathogen phagocytosis (184,
189, 190). Also like S. aureus, this internalization of B. burgdorferi depends on the
presence of β1 integrins, thereby suggesting that an Fn-binding protein could serve
as the mediator of this internalization (88). However, the authors of that study
found no role for BBK32, the most well characterized borrelial Fn-binding protein,
in this internalization process. By contrast, it is well-known that the S. aureus
protein, FnBPA, allows for bacterial uptake into host cells (107, 191). FnBPA has
elven repeats that, working in tandem, greatly enhance the ability of the protein to
promote internalization (114, 192). B. burgdorferi BBK32, by contrast, does not
have a similar repertoire of repeats, but does interact with Fn via a β-zipper
mechanism similar to that of other known Fn-binding proteins (125, 193). Again,
determining the mechanism that BB0347 uses to interact with Fn may help
determine if it will facilitate this internalization.
Even though BBK32 was not shown to specifically enable bacterial
internalization into host cells, the protein was found to promote binding of intact B.
burgdorferi to the surface of various host cell types (189). In fact, the first paper
characterizing BBK32 demonstrated a role for that protein in adhesion to a glass
slide coated with Fn (122). As we have shown that BB0347 is located on the outer
surface of B. burgdorferi, it too may promote adherence to these host cells and an
artificial matrix similarly to BBK32. Since the initiation of these studies, more work
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has been performed on the potential function and mechanisms of BB0347. Another
group has found that BB0347 does not promote enhanced attachment of B.
burgdorferi to endothelial cells in intravital microscopy of mouse blood vessels
(130). That same group also found that BB0347 has a lower affinity for Fn than
BBK32. Finally, the amount of Fn-binding by B. burgdorferi after deletion of BBK32
is minimal (122). All of these data, taken together, suggest that differences in B.
burgdorferi strains lacking BB0347 may be undetectable, if present at all. To verify
whether BB0347 may play a role in B. burgdorferi infection processes, we initiated
several studies characterizing the protein. These include analysis of 1) the
molecular characteristics of binding, 2) the regions of BB0347 and Fn involved in
any interactions, 3) the role of the protein in promoting adhesion of intact B.
burgdorferi spirochetes, and 4) the potential for the protein to be involved in host
cell internalization.

Materials and Methods
Bacterial strains and culture conditions
Borrelia burgdorferi strain MI-16, an infectious clone of the sequenced type
strain that contains all parental plasmids (167, 178), was used for the DNA source
for all borrelial proteins created in these studies. For the comparisons of wild-type
and knockout strains, the infectious clone 5A18NP1—lacking the plasmids lp28-4
and lp56 (194)—was kindly provided by Tao Lin and Steven Norris along with the
transposon mutant of bb0347 (bb0347 KO) in this background (195). To
complement the function of the bb0347 KO strain, bb0347 with 300 bp upstream of
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the start site were provided in trans on the borrelial shuttle vector pKFSS-1 (196).
Briefly, the bb0347 gene and promoter were amplified (Primer sequences in Table
3-1) from the DNA of B. burgdorferi MI-16 and cloned into pCR2.1 (Life
Technologies) as per manufacturer’s instructions. The insert was verified to have
the correct sequence by bi-directional Sanger sequencing (Eton Biosci; San Diego,
CA), and moved into pKFSS-1 by restriction endonuclease cloning using KpnI and
PstI (NEB). This cloning was again verified by sequencing. Bacteria were
transformed with the pKFSS1:bb0347 construct as detailed previously (197), and
clones were selected by plating, and screened for plasmid content via a multiplex
PCR (198) to verify the presence of all parental plasmids (194).
All spirochetes were grown in modified Barbour-Stoenner-Kelly (BSK II)
medium supplemented with 6% rabbit serum (Pel-Freeze, #A00274; Rogers, AR) at
23 or 34°C to cell densities of approximately 5×107 with the appropriate antibiotics,
when necessary. Additionally, One Shot TOP10 Escherichia coli (Life Technologies,
#C4040-06; Grand Island, NY) and chloramphenicol-resistant Rosetta(DE3)pLysS E.
coli (Novagen, #71401-4; Madison, WI) strains were used in cloning and production
of recombinant proteins, respectively.

Recombinant protein and peptide production
See materials and methods section of Chapter II for protocols related to
production of recombinant proteins and peptides. See Table 3-1 for a list of primers
used in the various cloning reactions. The plasmid encoding TP_0483 was a gift
from Dr. Caroline Cameron at the University of Victoria, British Columbia (108).
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Table 3-1) Primers used in Chapter III.
Name

Sequence (5'-3')

Use

Fla3*

GGGTCTCAAGCGTCTTGG

Amplification of flaB for QRT-PCR

Fla4*

GAACCGGTGCAGCCTGAG

CAB105

ACATTGAAAACGAAAAGGAA

CAB106

AAAGAATTTTTGCCCTTTTT

BB0347protF
BB0347protR

Amplification of bb0347 for QRT-PCR

CACCATGATAAAAATGTCTTTGAATTACACTG

Cloning of BB0347 into pET200

TTAGGTTTGATTTTTTATTTTTTTTATTAG

OspCprotF

CACCTGTAATAATTCAGGGAAAG

OspCprotR

TTAAGGTTTTTTTGGACTTTCTG

Cloning of OspC into pET200

FlaBprotF

CACCATTATCAATCATAATACATCAGCTA

FlaBprotR

TTATCTAAGCAATGACAATGACAAAACATATTGG

BBpep1F

CACCTGCTTAAATCCAAACACTACAAG

BBpep1R

TTAAATGATTCTTTCATTTTTCATTTG

BBpep2F

CACCTCTCTTGAGATTTTGCAAAAA

BBpep2R

TTAAAAGATTTCACCTGTTGTTTCTT

BBpep3F

CACCTTAAAAGCTAAAGAAATACATGAAAG

BBpep3R

TTATTTTTTAATTTGATCATTAAGCG

BBpep4F

CACCAGCTATACATCTTATTCTGAATTTCTTG

BBpep4R

TTATTGTTGTTTTAAAGAGTCTATTCTTTT

BBpep5F

CACCACCAATATAAAAGAATTGCTTATTG

BBpep5R

TTAGTTAATATTTAATAAAATCAATTCGCC

BBpep6F

CACCAAAATACAAAAAGGGATTAAAGAAA

BBpep6R

TTATATGGTTTTGAAAGAATTTTTGC

BBpep7F

CACCTTTAAAGCATATAAAAAGGGCA

BBpep7R

TTATTTTTCTTGATTATATTCTTCTTCCG

BBpep8F

CACCCAAAATCAATTAAAAGATAATCTAGATAAA

BBpep8R

TTACAAGCCTATTTTTGGCG

BBpep9F

CACCCATTTTACCTATTGTGGATTTGA

BBpep9R

TTAATTTTTTTGATTTTTAATAAAAACATAA

BB0347N-truncF

CCCTTCACCTGCTTAAATCCAAACACTACAAGATTC

BB0347N-truncR

ATTTAAGCAGGTGAAGGGATGATCCTTATCGTCATC

Cloning of FlaB into pET200

Cloning of BB0347 peptide 1 into pET200

Cloning of BB0347 peptide 2 into pET200

Cloning of BB0347 peptide 3 into pET200

Cloning of BB0347 peptide 4 into pET200

Cloning of BB0347 peptide 5 into pET200

Cloning of BB0347 peptide 6 into pET200

Cloning of BB0347 peptide 7 into pET200

Cloning of BB0347 peptide 8 into pET200

Cloning of BB0347 peptide 9 into pET200
Generation of BB0347 53-residue N-term
truncation

*primers were described previously (177)
Enzyme-linked immunosorbent assays
1.0 µg of various proteins in carbonite coating buffer (0.32 g Na2CO3, 0.586 g
NaHCO3 per 200 mL H2O) were coated overnight at 4°C on NUNC Maxisorp 96-well
plates (Thermo, #T-3020-2; Rochester, NY). The next day, the plates were blocked
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with 300 µL SEA BLOCK blocking buffer (Thermo, #37527), and treated with 100 µL
of varying concentrations of Fn (as listed in each figure) or rBB0347 (assays
pertaining to Fn proteolytic fragments) at 37°C for 1.5 hours. 100 µL of rabbit-αFn
antibodies (Sigma, #F3648; St. Louis, MO) were employed at a 1 500 dilution in PBS
to determine the level of Fn binding. Alternatively, for the Fahd assay, rabbit
polyclonal-αBB0347 (Proteintech, Chicago, IL) was used at a 1 1000 dilution. Goat
αRabbit-IgG antibodies conjugated to horseradish peroxidase (Pierce, #31460)
were then used at a 1

5000 dilution in PBS for detection (100 µL). All previous

steps, including the protein coating, were followed by three washes with PBS
supplemented with 0.05% (v/v) Tween-20. Next, as a substrate, 100 µl One Step
Turbo TMB (Thermo, #34022) was added per well, and the reaction was stopped
via addition of an equal volume of 2 N H2SO4. Absorbance was read at 450 nm with
an Epoch spectrophotometer with Gen5 data analysis software (BioTek; Winooski,
VT). KD was determined as the concentration of added protein at half-maximal
binding, assuming saturation, as described previously.

BB0347-Fn inhibition assays
ELISAs were performed as described above, but with minor modifications.
The PBS solution containing the Fn was supplemented with excess NaCl (0–600
mM), Heparin (0–2 mM–Calbiochem, #374858; San Diego, CA) or ε-aminocaproic
acid (0–300 mM–Sigma, #A7824). Alternatively, 96-well plates were coated as
above with 0.5 µg rBB0347 or rTP0483 and an inhibition assay was performed
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using Fn cell-binding domain-specific antibodies (Univ. of Iowa DSHB, #P1H11)
supplemented to a concentration of either 0 or 2.5 µg/mL with 5 µg/mL of human
Fn in PBS. For the inhibition of binding by BB0347 fragments, recombinant
peptides were added at final concentrations of 1 and 10µg to the Fn solution. For all
assays, binding was analyzed as detailed previously, starting with detection of Fnbinding with the αFn polyclonal antibodies. Binding was normalized to the 0 µg/mL
inhibitor level for each of the ELISAs.

RT-qPCR
B. burgdorferi was grown at two different temperatures to mid-log phase as
described above, then spun down at 4°C for 10 min at 6000×g and washed three
times with PBS with a spin following each wash. Total RNA was isolated from each
condition using the Trizol reagent (Ambion, #15596-018; Foster City, CA), and cDNA
was synthesized using the SuperScript III first strand synthesis system (Life
Technologies, #18080-051). Primers used for the RT-qPCR were Fla3 and Fla4
(177) to amplify flaB mRNA as a control and CAB105 and 106 to amplify bb0347
mRNA (Table 3-1). PCR was performed on a MyiQ2 Thermal Cycler with dedicated
software (Bio-Rad; Hercules, CA) and the run parameters were 95°C-3 min, (95°C30 sec, 48°C-30 sec)×40, 95°C-1 min, and, finally, a melt curve starting at 45°C with
Δ0.5°C in 10 sec intervals. Each reaction included a sample that lacked template and
a sample of RNA processed without reverse transcriptase to test for DNA
contamination of reagents.
Whole spirochete binding assays
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Glass slides were coated overnight with 20µg/mL human plasma Fn in PBS.
Subsequently, the Fn solution was aspirated, washed 3 times with 500µL PBS and
the slides were blocked with a 300µL solution of 1% bovine serum albumin in PBS.
Strains 5A18NP1 (parent strain), bb0347 KO, and bb0347 comp were enumerated
via darkfield microscopy and added to the slides at a density of 5 x106 bacteria/mL
in serum-free BSKII after a wash in PBS. These were allowed to bind for two hours
at 37°C, after which the plates were washed extensively and bacteria were
enumerated via darkfield microscopy. Spirochete numbers are reported as bacteria
per field of view at 400x total magnification.
To assess differences in binding to host cells, the three strains used above
were plated with L929 mouse fibroblasts grown to near confluence in 24-well plates
containing EMEM medium supplemented with 10% fetal bovine serum (FBS) at an
MOI of 20. After the times specified, the cells were washed extensively with PBS to
remove unattached B. burgdorferi, then trypsinized for 5 minutes at 37°C (.05%
Trypsin, 1x EDTA). Once cells were detached from bottom of the wells, trypsin was
inactivated by the addition of 3 volumes EMEM with 10% FBS. Bacterial numbers
were estimated using darkfield microscopy as described previously and normalized
to the total amount added to each well.

Statistical Analyses
Statistical analysis was carried out using either a two-tailed Student’s t-test
assuming unequal variance, or One-way Analysis of Variance (ANOVA) followed by a

44

Tukey’s post hoc test, when multiple comparisons were made. (*: p<0.05, **: p<0.01,
ns: not statistically significant for all figures).

Results

Figure 3-1) Expression of bb0347 is affected by temperature. The relative levels
of bb0347 mRNA (A) and protein (B) were assessed by RT-qPCR and Western
blotting, respectively. Results are indicative of three independent experiments, and
error bars indicate SEM
BB0347 expression characterization
In the preceding chapter, we showed that BB0347 is produced by B.
burgdorferi in culture. Knowing this, we also sought to initially characterize the
conditions under which this gene is active. One mechanism of gene regulation in B.
burgdorferi is temperature-dependent sensing of host environment. Genes found to
have products important for mammalian infections are typically more highly
expressed at temperatures mimicking those found in a warm-blooded host.
Accordingly, bb0347 mRNA was present at higher levels when the bacterium was
grown at 34°C than when cultured at 23°C (Fig. 3-1A). A comparison of BB0347
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protein levels at the same two temperatures by Western blot supported this finding
(Fig. 3-1B). These results suggest that expression of BB0347 is controlled, and the
protein most likely plays a role in infection of mammalian hosts. This bolsters the
hypothesis that BB0347 is important for allowing maximal binding of B. burgdorferi
to host tissues in vivo.

Figure 3-2) BB0347 binds Fn via an ionic mechanism. Using ELISA techniques,
we verified that BB0347 binds soluble human Fn (A), and that the interaction is at
least partially dependent on ionic forces (B and C), but we were unable to find a
function for lysine residues in BB0347-Fn binding events. All results are normalized
to BSA as a negative control.
BB0347-Fn binding assays
After we verified that BB0347 is produced by infectious B. burgdorferi, our
next objective was to determine whether or not the purified recombinant protein
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would be capable of directly binding Fn. Recombinant BB0347 and RevA (positive
control) were coated to an ELISA plate as described above, and various levels of Fn
were added to assess binding. Our rBB0347 bound the host protein in a dosedependent manner (Fig. 3-2A). This result supports the findings of a previous study
in which surface plasmon resonance was used to quantify the binding between
BB0347and Fn (130).
Since BB0347 has only recently been shown to directly bind Fn in vitro, the
mechanisms of this binding are largely unknown. Previous studies have shown that
the binding of Fn by several proteins is dependent on the ionic strength of the
solution of incubation. To determine if ionic interactions play a role in binding of
BB0347 to Fn, a sodium chloride inhibition assay was performed (Fig. 3-2B). This
assay works by releasing free ions into the buffer, thereby inhibiting interactions
between potentially important charged residues on each protein. Increasing the
NaCl concentration of the interaction buffer caused the binding between Fn and
rBB0347 to decrease dramatically, implicating ionic forces from charged residues in
the interaction of these two proteins. To verify these observations, we repeated the
test with the physiological salt lithium heparin.
A heparin inhibition assay can work in two ways. Firstly, it is a negatively
charged polysaccharide often found in the ECM, so it can function to inhibit ionic
interactions like a NaCl inhibition assay (199). Additionally, heparin is known to
bind Fn, and can, therefore, also indicate if a given protein is competing at known
heparin-binding sites (200). We found that the addition of heparin inhibited the
binding of Fn (Fig. 3-2C) by rBB0347, and that this inhibition was much more potent
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than that of NaCl. For example, binding was reduced by 40% after the addition of an
estimated 50 µM heparin, while the same level of inhibition was not seen with the
sodium chloride inhibition assay until a concentration of 75 mM NaCl (Fig. 3-2B).
This indicates a more efficient form of inhibition occurs upon the addition of
heparin to a BB0347-Fn binding phenomenon, even though the molar mass of
heparin in our reagent can only be estimated, as the difference in inhibition strength
was approximately 1000-fold. However, our data also suggest that non-ionic (e.g.
hydrophobic) interactions may also play a role in Fn-BB0347 binding, as we were
unable to completely eliminate binding with either salt.

Figure 3-3) BB0347 interacts with several domains of Fn. A) Fn with or without
pretreatment with anti-CBD antibodies was added to wells with immobilized
BB0347 or TP0483 as a control and washed extensively. Inhibition was measured
by comparing the amounts of Fn bound with or without anti-CBD. B) Various
proteolytic fragments of Fn were immobilized in 96-wells plates, then incubated
with increasing concentrations of recombinant BB0347 and binding was analyzed
using an ELISA and anti-BB0347 antibodies.
Additionally, many lysine residues are present in the primary structure of
BB0347. As charged residues were implicated in BB0347-Fn binding, positively
charged lysines could function as a source of these ionic interactions. To investigate
this hypothesis, ε-aminocaproic acid (εACA, or 6-ACA) was added to the ELISA
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buffer in a manner similar to NaCl and heparin in the previous experiments. 6-ACA,
as a lysine analogue, will competitively inhibit the activity of any lysine-recognizing
residues in either protein (172, 201). In our experiments, we were unable to find a
role for lysine residues in the binding of rBB0347 to Fn, even upon the addition of
up to 300 mM of 6-ACA (Fig. 3-2D).

Fn domain characterizations
As discussed previously, Fn is composed of multiple distinct domains, each
with a unique function and set of binding partners. Determining which Fn region is
bound may help us further define the role of BB0347 in a B. burgdorferi infection.
Firstly, we sought to analyze whether BB0347 interacts with the cell-binding
domain (CBD) of Fn. To evaluate the binding between BB0347 and the FnCBD, we
used monoclonal antibodies targeting the CBD in an inhibition assay (Fig. 3-3A). No
difference was seen in binding between rBB0347 and Fn, however, our positive
control (rTP0483) showed a statistically significant decrease in binding. This result
suggests that the CBD is not essential for the binding of BB0347 to Fn.
Since BB0347 did not appear to interact exclusively with the CBD of Fn (Fig. 3-3A),
and heparin was very potent in inhibiting the binding of these two proteins (Fig. 32C), we sought to examine the interactions between BB0347 and Fn potentially
modulated by heparin. Full length Fn has two distinct heparin-binding domains, one
located on the N-terminus and another located nearer to the C-terminus on the
opposite side of the cell-binding domain. Both of these domains are available
commercially as proteolytic fragments of Fn. Additionally, the N-terminal gelatin-
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binding domain (GBD) is also available commercially as a purified protein fragment.
We analyzed the ability of BB0347 to interact with these several domains via ELISA.
Surprisingly, we found that BB0347 was able to bind to all three at levels equivalent
to WT binding (Fig. 3-3B). This observation led us to hypothesize that BB0347
itself may have multiple independent domains capable of interacting with distinct
regions of Fn.

BB0347 recombinant peptides
To determine if BB0347 contains multiple regions capable of interacting with
Fn, we generated several derivatives of the protein. Firstly, we removed 53 residues
from the N terminus of the protein via overlap deletion PCR (see materials and
methods section, this chapter). The resultant rBB0347∆N53 was much easier to
express in E. coli (data not shown) and bound Fn equivalently to the full-length
BB0347 used previously (Fig. 3-4A). Additionally, 100-residue recombinant
peptides were produced starting at residue 54 and overlapping by 50 amino acids
each. Even more surprising than our results for the different domains of Fn, we
found that every 100-residue peptide was able to bind Fn, although affinities varied
(Fig. 3-4B). To verify whether this binding was specific, we performed inhibition
assays by pre-incubating Fn with the peptides prior to addition to ELISA plates
coated with rBB0347∆N53. Here nearly all peptides were able to inhibit binding of
Fn to the immobilized protein at the concentrations tested (Fig. 3-4C), suggesting
that these interactions are specific. Interestingly, for reasons that have yet to be
characterized, one peptide assayed actually increased binding of BB0347 to Fn.
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Figure 3-4) Multiple peptides from BB0347 bind fibronectin. ELISAs were
performed comparing full length BB0347 to A) An N-terminal truncation and B)
multiple 100-resudue overlapping peptides derived from the protein. C)
Immobilized BB0347 was assessed for binding to Fn that was simultaneously added
in the presence of the peptides from (B).
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Having characterized BB0347 using recombinant proteins, we next sought to
observe the role of the protein in intact spirochetes.

Figure 3-5) BB0347 enhances bacterial adhesion to an artificial Fn matrix.
Bacteria were incubated with Fn-coated glass slides as detailed in the materials and
methods section. Statistically significant differences were seen between wild type
and knockout bacteria as well as between wells treated with BB0347 vs. those
treated with BSA.
Whole spirochete-Fn interactions
To begin characterizing the role of BB0347 in intact B. burgdorferi, we
performed an assay analyzing binding to an artificial fibronectin matrix on a glass
slide. Slides were coated with Fn as detailed in the materials and methods section
and previously published by others. We compared the binding abilities of bacteria
having and lacking BB0347 as well as the effect of adding soluble rBB0347∆N53 to
the system. We found that spirochetes lacking BB0347 were less able to bind Fn
when compared to their parent strain. Furthermore, the addition of rBB0347∆N53
to the binding reactions also inhibited the interactions of wild-type bacteria, while
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no difference was detected in the bb0347 mutant bacteria after treatment with
additional protein (Fig. 3-5). These results suggest that BB0347 may aid in
colonization of host tissues containing fibronectin.
To further define the function of BB0347 in B. burgdorferi’s ability to bind to
tissues, we analyzed the bacterium’s ability to bind to mouse fibroblasts, an in vivo
source of Fn. Other studies have shown decreased binding to fibroblasts in B.
burgdorferi lacking BBK32, another Fn-binding protein. We saw significant
differences in the number of recovered bacteria when comparing the parent and
bb0347 KO strains at both 24 and 48 hours (Fig. 3-6). Again, our results suggest that
B. burgdorferi adhesion to Fn is enhanced by the presence of BB0347. Overall, these
in vitro binding assays indicate that BB0347 may function as an adhesion for whole
spirochetes.

Discussion
It is not particularly surprising that we have identified another Fn-binding
protein from B. burgdorferi. Many different bacteria encode numerous adhesins,
including multiple independent proteins targeting host Fn (115, 124, 202).
However, during our characterization of the protein, we did detect a number of
interesting phenomena. Firstly, the mechanisms permitting BB0347-Fn interactions
appear to be mostly ionic in nature. This is different than a recently characterized
protein from B. burgdorferi, RevA, which was not inhibited by any of the ionic
concentrations tested (120). This may indicate the functions of RevA and BB0347
are different in live spirochetes, as Fn is a multi-domain protein with great potential
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for distinct uses by bacterial adhesins (83), and suggests that even though the
protein target of BB0347 and RevA is shared, the proteins are not redundant. We
also found it surprising that a BB0347-Fn binding reaction treated with the lysine
analogue 6-ACA did not yield decreased binding. BB0347 has a high number of
lysines, which could, in theory, be the charged molecules inhibited by the addition of
high concentrations of NaCl. The fact that no reduction in binding was seen after 6ACA treatment, however, may also be taken as further evidence of the specificity of
BB0347-Fn interactions, as inhibiting this group of charged residues would most
likely have an impact on non-specific interactions.

Figure 3-6) BB0347 promotes adherence to L929 fibroblasts. Live B.
burgdorferi parent and bb0347 KO strains were incubated with mouse L929
fibroblasts for 24 and 48 hours at an MOI of 20. Numbers displayed are
Our most surprising results were the fact that BB0347 can interact with
multiple domains of Fn, and that multiple different binding sites on BB0347 may
mediate this binding. It is not uncommon for bacterial adhesins to possess multiple
binding domains and functions (94, 203–205). The phenomenon is well known
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even in B. burgdorferi. BBK32 has at least two domains with which it can interact
with Fn in addition to other sequences that allow it to bind host GAGs (119, 123,
206). What was surprising was that the entire protein appears to encompass
multiple independent Fn-binding regions. However, it should be noted that the Fnbinding region of S. aureus FnBPA, one of the best-characterized Fn-binding
proteins, contains 11 distinct Fn-binding regions spanning nearly 400 amino acids,
which would make the characterized Fn-binding region of BB0347 just slightly
larger than a well-characterized Fn-binding region of a paradigmatic bacterial Fn
receptor.
This potential similarity to FnBPA was also led us to consider the role of
BB0347 in internalization of the bacterium by non-professional phagocytes.
Previous work on B. burgdorferi internalization implicated B1-integrins—cell
surface receptors that can bind Fn (88)—in the uptake of intact spirochetes. If B.
burgdorferi uses a mechanism similar to that of S. aureus, it could use the Fn as an
adaptor molecule that facilitates bacterial cell uptake (113) However, we were
unable to perform a gentamycin protection assay as used previously for B.
burgdorferi (189), as the parent strain of B. burgdorferi, 5A18NP1 was not able to
be recovered after such a treatment. However, in preliminary experiments, we were
able to recover another transformable, infectious strain, B. burgdorferi A3 (207),
after equivalent treatment. To test the importance of BB0347 in spirochete uptake
by fibroblasts, we will have to create a BB0347-inactive mutant using that
background strain in the future. Also of interest, the plasmids missing from B.
burgdorferi 5A18NP1 may be the factor permitting bacterial survival during a

55

gentamycin protection assay. Whether this is true, and whether factors encoded by
one or both of the plasmids allows for internalization, or permit survival after entry
into the host cell is unknown. Clearly, further work is needed, but this observation
may prove important in elucidating the physiology of host cell invasion by the
spirochete.
The final observed phenomenon that was surprising to us was the defect in
binding ability of whole B. burgdorferi BB0347 mutant spirochetes to an artificial Fn
matrix as well as to Fn-producing mouse fibroblasts. Although we did show herein
that BB0347 binds fibronectin and is surface exposed, previous studies have found
that is has a much lower affinity for Fn than BBK32 (130), and that a loss of BBK32
leads to minimal background for binding to both slides (122), and cell monolayers
(189). Taken together, these previous studies would suggest that the role of
BB0347 in attachment to immobilized Fn would be minimal, if even detectable.
Contrary to this hypothesis, loss of BB0347 and addition of soluble recombinant
BB0347∆N53 both significantly inhibited binding of intact B. burgdorferi spirochetes
to an artificial Fn matrix, and lack of BB0347 also resulted in decreased binding to
L929 fibroblast cells. Furthermore, these numbers cannot simply be accounted for
as the background binding seen in the previous studies, as the reduction in
spirochete numbers after the loss of BB0347 was 85% for slides, and 68% for host
cells, both of which are comparable to the numbers seen in BBK32 whole spirochete
binding studies (122, 189).
The reasons for these observed phenomena still require characterization, but
one explanation could be that the functions of the several Fn-binding proteins of B.
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burgdorferi are not truly redundant. Instead, the proteins may work in tandem to
enhance the Fn-binding activity of the intact spirochetes. Many other ECM proteins
work in a similar fashion, for example, plasminogen, when bound by some bacterial
adhesins, adopts a conformation permissive of activation by other host factors (172,
208, 209). Indeed, Fn itself adopts a form more conducive to integrin binding after
interaction with different bacterial adhesins(116, 210) Future studies analyzing
the interplay between BBK32, BB0237, and Fn may help elucidate the molecular
basis behind our observed cell-binding phenomena.
The characterization of BB0347 as an Fn-binding protein that promotes
adherence to host cell monolayers and an artificial Fn matrix led us to hypothesize
that BB0347 may be important in the colonization of the vertebrate host. This is
bolstered by the observation that the expression of bb0347 is up-regulated when the
spirochetes are grown at 34°C, a condition known to somewhat mimic growth in an
infected mammal (211). Our next objective for BB0347 will be to characterize the
role of this protein in a mammalian infection.
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CHAPTER IV
IN VITRO CHARACTERIZATION OF MLPJ-HEMIN INTERACTIONS

Rationale
The lack of a need for iron in B. burgdorferi is unique among mammalian
pathogens (165). The only other characterized bacterium with no observable
metabolic requirements for iron is the saprophytic species Lactobacillus plantarum
(212). In other bacteria, the need for iron is well documented. All known bacteria
except for these two species cannot replicate or function without acquiring iron
from their environments (213–218). These organisms that require iron incorporate
this element into proteins to form functioning enzymes including superoxide
dismutase and cytochromes used in the bacterial electron transport system (219–
221). However, the means by which pathogenic bacteria have evolved to acquire
iron from their host organisms can often be highly immunogenic, and often involve
lysis of host cells. Iron is rarely present in eukaryotic organisms as a free-floating
metal; instead, host cells will sequester iron in protein complexes, such as
hemoglobin (218, 222); regardless, nearly all pathogenic bacteria have evolved
mechanisms by which to acquire the needed iron (152).
In addition to these complications, free iron is innately hazardous to cellular
function. Uninhibited iron ions can lead to the formation of oxygen free radicals,
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also called reactive oxygen species (ROS) via the Fenton reaction(223). These ROS
can damage cells in a number of ways, either by attacking DNA (224), disrupting cell
membranes (225), or by oxidizing (and thereby inactivating) essential cellular
proteins (226, 227). In humans, ROS are the key cause of cellular and organ damage
in patients with hemochromatosis (228). Accordingly, bacteria, including B.
burgdorferi, often code for enzymes capable of transforming ROS into less harmful
compounds such as hydrogen peroxide (166).
Although the Lyme disease spirochete does not use iron, it still may come in
contact with this metal in a host environment. For example, during the initial stages
of infection, Lyme disease often presents with a rash known as erythema migrans
(9), inflammation often results in the release of antimicrobial compounds by the
host (229, 230), including toxic proteins that require iron as a cofactor (226). If B.
burgdorferi were to lack proteins capable of sequestering and inactivating this iron,
the spirochete could receive a lethal or debilitating dose of this toxic metal during
mammalian infection. Binding of iron for prevention of ROS formation is not an
uncharacterized phenomenon. For example, the E. coli protein Dps will bind and
inactivate iron in cell-stressing conditions to prevent DNA damage (231). Humans
also encode a small protein called siderocalin that can also deactivate iron and
prevent cellular harm (151).
Recently, a B. burgdorferi cytosolic iron and copper-binding protein (BicA)
was suggested to be important for bacterial survival (168), but the fact remains that
very few metal ions are present in the cytosol under normal conditions (165), and
no known transporter for iron exists in the spirochete (166). Additionally, upon
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deletion of an Mn transporter, B. burgdorferi was observed to have an increased
amount of bound iron molecules (168), and other research has shown that lowering
intracellular Mn concentrations activates the production of the mammalian host
response sigma factor (RpoS) in the spirochete, as detailed in the introduction
(170).

Figure 4-1) MlpJ is dissimilar to the other Mlps of B. burgdorferi B31. A clustal
alignment of Mlp family members shows little sequence identity between MlpJ and
other Mlp proteins. All proteins, however appear to have a similar N terminus with
a lipobox domain [49], probably to allow for targeting to the outer membrane of the
spirochete.
Among the genes whose transcription are upregulated by RpoS is the Mlp
family of lipoproteins (147). This family has been described previously in B.
burgdorferi, but the function of the proteins has not been investigated (146–149).
However, research has shown some of the factors involved in the regulation of the
mlp genes, and that the proteins are immunogenic. Analysis of the proteins’ primary
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sequence also suggests that the proteins are located on the outer membrane of the
didermic spirochete. There also appears to be a high level of redundancy. At least
ten members of this family have been found, though not all are present in every
strain of B. burgdorferi (148), as the mlp genes are found on extra-chromosomal
elements of the borrelial genome whose content may vary between strains (178).
The genes for mlpA through mlpI are found on members of the circular plasmid 32
family, whereas mlpJ is found on linear plasmid 56, at least in the infectious type
strain B. burgdorferi B31. However, even though the Mlp proteins in B. burgdorferi
B31 are grouped into single family, MlpJ is distinctly different from those other
members in B. burgdorferi strain B31 (Fig. 4-1). The corresponding function of MlpJ
may, therefore, be distinct from that of the other Mlp proteins.

Figure 4-2) MlpJ is homologous to NlpH. Clustal alignment of MlpJ with the
characterized NlpH from B. afzelii reveals significant sequence identity between the
two proteins, including at potential NEAT domains (underlined in red).
Even though no function has yet been described for MlpJ (or the entire
family), a protein was found in the European Lyme disease spirochete, Borrelia
afzelii, which is homologous to MlpJ (Fig. 4-2). The B. afzelii protein is called NlpH,
and previous work demonstrates that NlpH is able to bind the host compound
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hemin (150). Hemin is an iron-containing molecule that is frequently a target of
pathogenic bacteria, which often scavenge the iron for use in bacterial enzymes
(163, 232). In performing the following studies, we sought to determine whether
MlpJ bound hemin, and, if so, what the effect on the bacterium would be. We
initially hypothesized that hemin binding by MlpJ would render the bacterium less
susceptible to the toxic effects of hemin.

Materials and Methods
Hemin Binding assays
Recombinant bacterial proteins were produced as described in previous
chapters. To assess hemin binding, proteins were suspended in 100µL of PBS at
0.1mg/mL with 20µM hemin (from a 1mM hemin stock in DMSO) for one hour at
37°C. Proteins also incubated with DMSO as a vector background control. After
incubation, the proteins were analyzed on the spectrophotometer used in previous
studies described herein with absorbances read at for the range of 280-600nm with
gradations of 10nm. A peak at 400nm is indicative of hemin binding. His-tagged
OspC was used as a negative control and BSA, a known hemin-binding protein (233)
was used as a positive control.

Creation of MlpJ-deficient B. burgdorferi
To create strains of B. burgdorferi not producing MlpJ, the gene was
insertionally inactivated. To facilitate this, a region of lp56 including 500bp up-anddownstream of mlpJ was cloned into the suicide vector pCR2.1. Subsequently, a PCR
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fragment of PflgB-GentR was amplified from the plasmid pBSV2G using primers with
flanking MfeI restriction endonuclease sites (Primers, F: CTC TCT CTC TCA ATT GTA
CCC GAG CTT CAA GGA AG-3’ R: 5’-CTC TCT CTC TCA ATT GAA CGA ATT GTT AGG
TGG CG-3’). The pCR2.1-mlpJ construct and PCR product were both digested with
MfeI (NEB), and placed into a ligation reaction overnight at 15°C. The next day,
ligation product was transformed into E. coli TOP10, and colonies were screened for
kanamycin and gentamycin resistance. Plasmids were isolated via midiprep kit
(Qiagen) and sequenced with bi-directional Sanger sequencing. Plasmids were
transformed into B. burgdorferi A3, an infectious strain of the spirochete lacking
only circular plasmid 9 as previously described (197). Individual clones were
selected from agar and screened via multiplex PCR to verify plasmid content (198).
The clones were also screened to verify sensitivity to kanamycin, thereby verifying
the loss of the suicide vector backbone.
To complement the gene, mlpJ with 300bp upstream of the start site was
cloned into pJAH2, a plasmid encoding kanamycin resistance (234). Briefly, the
gene and promoter were amplified via PCR (Primers, F: 5’-GAA CTT AAT ACT AAA
ATA GAC AAT GTA GAA AA-3’ R: 5’-AAT GTT TTT AGT TTT GCC AAT TAG-3’), cloned
into pCR2.1, and insertion was verified as above. The PmlpJ-mlpJ in pCR2.1 construct
and pJAH2 were subsequently digested with KpnI and XbaI (NEB). And the small
product from the pCR2.1 digest was purified with a Qiaquick gel extraction kit
(Qiagen) and incubated in a ligation reaction with the digested pJAH2 overnight at
15°C. All steps that followed are equivalent to those used in the knockout
generation.
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To verify the loss and recovery of MlpJ in the knockout and
complement strains, respectively, we utilized the antibodies we had produced
against MlpJ to analyze for protein presence. Parameters used were equivalent to
those used in the control lane of the protease protection assay for MlpJ detailed in
Chapter II.

Hemin challenge assay
B. burgdorferi strains were cultured in BSKII until they reached a density of 5
x 107 bacteria/mL (mid-log phase). At this point, the bacteria were diluted 1:100 in
fresh BSKII supplemented with 20µM hemin or the equivalent volume of DMSO as a
vector control. Bacterial densities were estimated by counting the number of
spirochetes per field of view at one and three days post-inoculation. Numbers of
bacteria surviving hemin treatment were normalized to each strain’s cell density in
the DMSO-treated samples to account for differences in strain growth rates.

Results
MlpJ-hemin binding
To determine the role of MlpJ in the survival and pathogenesis of B.
burgdorferi, we initially sought to verify that MlpJ is a hemin binding protein. After
incubation of purified recombinant MlpJ with hemin, we saw a dose-dependent
increase in the absorbance at approximate 400nm, which is indicative of hemin
binding (Fig. 4-3). As the recombinant protein is purified via the use of a histidine
tag, we also verified that this tag region would not produce hemin binding itself by
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using a his-tagged rOspC as a negative control. Bovine serum albumin served as a
positive control for the assay, as it has known hemin-binding qualities. We next
sought to investigate the function of MlpJ in the physiology of the spirochete.

Figure 4-3) MlpJ binds hemin in a dose-dependent manner. Samples were
analyzed as described in the materials and methods section of this chapter. OspC
was used as a histidine-tagged negative control and BSA as a positive for hemin
binding.
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Confirmation of MlpJ knockout
To identify the role of MlpJ in live bacteria, we generated an mlpJ knockout
strain of B. burgdorferi A3 using insertional mutagenesis. A schematic of the suicide
vector used to replace the natural mlpJ site via homologous recombination (235) is
provided (Fig. 4-4). Furthermore, we provided the gene with its putative native
promoter in trans in the MCS of the B. burgdorferi shuttle vector pJAH2 (234) in the
mlpJ knockout background.

Figure 4-4) Schematic of the plasmid used to inactivate mlpJ. A gentamycin
resistance gene driven by the constitutive FlgB promoter from B. burgdorferi was
used to interrupt the mlpJ coding region. This plasmid was then transformed into B.
burgdorferi A3, and the interrupted non-functional, gene replaced the natural mlpJ
gene via homologous recombination.
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We verified the inactivation of the gene by using a Western blot specific to
MlpJ protein to confirm absence of MlpJ in the expected strain (Fig. 4-5). Both the
WT and complemented strains were positive for MlpJ, while the KO lane did not
display any protein bands. These data confirm that we can use our two strains in
direct comparison for various biological tests, including in vitro and in vivo assays of
mlpJ function.

Figure 4-5) MlpJ is not produced in the mlpJ KO B. burgdorferi. A Western blot
probing for MlpJ protein using in-house produced antibodies reveals that the
protein is absent from the mlpJ KO strain, and is present again when mlpJ is
provided in trans on the shuttle vector pJAH2.
Hemin inhibition of bacterial growth
As discussed above, hemin is known to be toxic to bacteria due to its redox
potential for forming reactive oxygen species. We hypothesized that MlpJ might
function as a protective agent under an acute hemin challenge by binding the
protein and inhibiting the redox activity of the iron cofactor. To test this hypothesis,
we challenged both mlpJ WT and KO strains with hemin in culture (Fig. 4-6). After
day 3, there was a significant decrease in bacterial numbers compared to the DMSOtreated (untreated) samples in both the KO and WT strains. However, the growth
retardation was more strongly pronounced in the WT strain. This result suggests
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that the presence of MlpJ is deleterious during an acute hemin challenge, and that
the binding of hemin by MlpJ does not successfully inactivate the redox potential of
this iron-containing compound.

Figure 4-6) MlpJ is deleterious during a hemin challenge. B. burgdorferi growth
was measured during an incubation with hemin, and each strain was normalized to
a vector-treated control (DMSO). *: indicates p<0.05 as determined by One-Way
ANOVA compared to WT at the same time point.
Discussion
The unique phenomenon of hemin binding to MlpJ in the absence of a known
function for iron in the host spirochetes is a puzzling occurrence. Other bacteria
would use the hemin as a source for iron or leave the hemin intact as a redox center
for beneficial cellular processes. B. burgdorferi, on the other hand, has no such
requirements of the hemin it binds. In fact, binding to hemin appears to be
deleterious to the bacterium in vitro. Why then, does the bacterium bother to bind
hemin at all, and why does the expression of the mlpJ gene increase under
mammalian-like conditions?
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One possible explanation is that hemin binding is not the only job of MlpJ.
Multiple proteins capable of carrying out diverse functions in the spirochete have
already been discovered. Notably, enolase not only carries out glycolytic functions
in the bacterium, but also changes sub-localization to the outer surface of the
bacterium, where it can function as a receptor for host plasminogen. It’s not difficult
to imagine that MlpJ, already present on the outer surface, may serve another
function or multiple functions in addition to binding hemin. Indeed, hemin binding
may only be an ancillary or unintended function of the protein.
It is also unknown at what point the spirochete may come into contact with
host hemin. It may be that during mammalian host infection (conditions that upregulate the expression of the gene) the microenvironment in the milieu
surrounding the spirochetes may have cell lysis released hemin, even if these
phenomena aren’t observed on a large scale in B. burgdorferi infected organisms.
However, the question remains as to the purpose of this hemin acquisition, if the
bacterium not only has no use for the hemin, but also is actively harmed by the
molecule.
An answer may lie in alternative functions of hemin other than as a redox
center and carrier of host oxygen. Hemin is immunogenic, and released hemin may
react with host cells by producing ROS. By absorbing the hemin to its own surface,
the bacterium may prevent a localized immune response. Hemin is additionally
known to signal through Toll-like receptor 4 (TLR4) in macrophages (236).
Curiously, the expression of tlr4 in B. burgdorferi-treated mouse leukocytes is
increased, even though B. burgdorferi has no endotoxin, the classic activator of TLR4
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(51). Another alternative use for hemin is as a cofactor for neutrophil
myeloperoxidase (237, 238). B. burgdorferi infection in mice has been shown to
induce the formation of neutrophil extracellular traps (NETs) (239), complex
bundles of DNA, chromatin, and bactericidal compounds produced during a special
kind of neutrophil programmed cell death known as NETosis (230). These NETs
have been shown to trap and kill B. burgdorferi in vitro, and are induced in infected
mice. One important observation regarding these NETosis killing experiments is
that the strain of B. burgdorferi the researchers used lacks lp56, the plasmid
encoding for MlpJ (240). Further studies comparing the survivability of B.
burgdorferi during NETosis phenomena may reveal a role for MlpJ in this survival.
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CHAPTER V
THE ROLES OF BB0347 AND MLPJ IN A B. BURGDORFERI INFECTION

Rationale
Although we have observed measureable changes in spirochete behavior in
our in vitro studies of BB0347 and MlpJ, the practicality of these proteins in a
mammalian infection has yet to be qualified. Often, proteins may have roles that are
unimportant in the actual life cycle of the bacterium. For instance, if a protein is
redundant, it may be hard to discern the specific role without removing the other
redundant proteins. In S. aureus, the Fn-binding proteins FnBPA and FnBPB are
each adequate to promote wild-type levels of bacterial virulence (115). By
inactivating both proteins, researchers were able to observe a measureable
difference in bacterial virulence (107). BB0347 has at least four potential
redundancy partners in B. burgdorferi, and there may be even more Fn-binding
proteins encoded by the spirochete yet to be characterized (124). Although we
observed phenomena during the in vitro studies that suggested that the roles of the
Fn-binding proteins are not truly redundant (see chapter 3), the in vivo environment
is not equivalent in its complexity and selection pressures. Likewise, MlpJ may
render the spirochete more susceptible to a hemin challenge in vitro, but the
question remains as to whether the spirochete will even encounter such a challenge
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during the course of a normal infection. Even if such conditions are encountered,
there may also be other proteins able to interact with hemin in a manner similar to
MlpJ. Although no MlpJ homologues (except for MlpJ itself) appear in B. burgdorferi
B31 derivatives, such as those used in the studies described herein, B. burgdorferi
297 does have proteins similar in sequence to MlpJ (149). Other, non-homologous,
proteins may also have roles in hemin binding, resulting in a potential for
redundancy, as seen with the Fn-binding proteins.
The most commonly used model for a mammalian B. burgdorferi infection is
a mouse (131). In the wild, mice are naturally competent reservoirs of B.
burgdorferi sensu stricto. Once infected with B. burgdorferi, a mouse is potentially a
carrier for the bacterium until the animal’s death. Mice infected with the spirochete
are also usually symptom free, although arthritis can be induced by the infection of
young C3H mice (241). The inoculation of mice with wild-type strains of B.
burgdorferi is most effective when performed subcutaneously via a needle injection,
and the ID50 can commonly fall into the tens of spirochetes (194). This murine
model has been shown on numerous occasions to reveal differences in bacterial
infectivity with a number of B. burgdorferi adhesion protein knockout strains (126,
129, 131, 242).
Notably, BBK32 knockout strains display a decreased early infectivity, but
appear to eventually recover to wild-type levels in the various tissues of infected
animals (127, 129). Studies performed 3 weeks post-infection have found
conflicting results over whether BBK32 mutant bacteria display different levels of
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infectivity; further highlighting the difficulty of studying these virulence factors in
the pathogenesis and persistence of B. burgdorferi (126, 127).
There are two common methods for identifying the murine infectivity
potential of B. burgdorferi mutants to their respective wild-type strains after a
needle inoculation of the animal with the bacterium. Often, these techniques are
employed in tandem to ensure that any potential phenotypes are observed. The
first protocol is the direct culture of organs from infected animals in the B.
burgdorferi growth medium, BSKII, and subsequent assessment of spirochete
growth via microscopy (126). This allows for gross assessment of bacterial
presence in these organs, and is likely the most sensitive of the two assays used.
Potentially, the presence of a single bacterium could yield a positive result via this
culture-based detection method, as the bacterium would replicate over time in
culture to the point of detectability. However, direct culture, while sensitive, is not a
highly quantitative assessment of bacterial burden of the cultured organs. In many
other bacteria, bacterial burden can be quantified by direct plating of the organ in
question onto solid growth medium (as opposed to the liquid BSKII) to determine
the bacterial colony forming units relative to the amount of tissue used. In B.
burgdorferi, plating is a prohibitively difficult process, and bacterial burdens are
potentially so low that this technique is not sensitive enough to detect or quantify
spirochete burden (138). Instead, the second common protocol used to assess a B.
burgdorferi strain’s infectivity is qPCR (127, 243, 244). In this method, bacteria are
quantified by the relative amount of bacterial/host DNA. While this method is not
as sensitive as the direct culture protocol (one would not, for instance, be able to
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detect a single bacterium in a host organ), qPCR allows for a more precise measure
of bacterial load. Although both culture and qPCR utilized in tandem can allow for
relatively precise measurement of B. burgdorferi infectivity, the fact remains that
mice are not infected in the wild by researchers with needles.
As mentioned in the introduction to this dissertation, the B. burgdorferi
infection cycle is maintained in the wild by Ixodes ticks. In order for B. burgdorferi
to be maintained in the wild, each of the following statements regarding B.
burgdorferi spirochetes must be true, they must be able to: 1) move from the tick
into the larger animal, 2) successfully colonize the new host, 3) prevent clearance by
the host immune system, 4) be able to be re-transmitted into a new tick vector, and
5) survive inside the tick host until the next blood meal (23). In addition to these
requirements, infection of animals via a tick is fundamentally different that via a
needle. Ixodes ticks have a plethora of factors involved in the formation and
maintenance of a feeding pit, including secretions that modulate the host immune
response, which may help B. burgdorferi survive during the initial stages of infection
(23, 245). To measure the role of these potentially infection-enhancing tick
proteins, and the function of a given B. burgdorferi protein at each of the abovedescribed life cycle steps, we can replicate the infectious cycle in the laboratory. To
facilitate this, we first infect mice via needle with B. burgdorferi. We can then feed
naïve (uninfected) larval ticks on the infected mice, let those ticks molt to their next
life stage (nymphs), and then feed these infected nymphs on naïve mice. At each
stage of the infection, we can assess the survival of the bacterium, thereby validating
whether the protein(s) of interest have any effects on an in-lab B. burgdorferi life
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cycle that simulates the challenges a bacterial strain would encounter its natural
habitats.

Materials and Methods
Animals and ethics statement
The protocol for animal infection was approved by the University of North
Dakota Institutional Animal Care and Use Committee (IACUC protocol #1101-2), in
accordance with Association for Assessment and Accreditation of Laboratory
Animal Care guidelines (Animal Welfare Assurance: A3917-01). Mice used for this
study were female C3H/HeNHsd (Harlan; Madison, WI), and were cared for under
the guidelines of the National Research Council of the National Academics Guide for
the Care and Use of Laboratory Animals (8th Edition). All efforts were made to
minimize animal suffering.

Bacterial strains and culture conditions
Bacteria used in this study were as follows. For BB0347, 5A18NP1, bb0347
KO, and bb0347 comp strains were used as detailed in Chapter III of this
dissertation. A3, mlpJ KO, and mlpJ comp bacteria were also used as described in
Chapter IV. All bacteria used for infection studies were grown to an approximate
density of 5 x 107 cells/mL in BSKII, as previously described. Bacteria were kept at a
low passage number (less than 6 passes since last assessment for plasmid content)
prior to animal infections, to prevent loss of plasmids necessary for infectivity
(246).
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Infection of mice by needle
To infect mice with the appropriate number of spirochetes, the bacterial
strains used were enumerated with a Petroff-Hausser counting chamber designed
for used with bacteria and sperm. Bacterial cultures were then diluted to the
appropriate concentration with additional fresh BSKII. Mice were infected
subcutaneously in the intrascapular region of their backs with 100µL of
appropriately diluted bacterial cultures. At the time points detailed in the results
section, mice were incapacitated with CO2, and killed by cervical dislocation, after
which point the desired tissues were removed and placed in BSKII culture medium
or flash-frozen in liquid nitrogen for later use in qPCR analysis. Tissues used for
both protocols were ear, tibiotarsal joint, heart, and bladder.

Culture of mouse tissues
Mouse tissues harvested were placed directly into 5 mL BSKII medium
supplemented with rifampicin to prevent growth of other contaminating bacterial
species (247, 248). Tissues were allowed to remain in culture for one week without
perturbation to allow for bacterial growth in the culture. After this point, cultures
were assessed for bacterial growth via darkfield microscopy. Cultures that had no
growth after one week were diluted 1:50 in fresh BSKII medium without antibiotics,
and the parent cultures were also kept. Cultures were monitored weekly for the
next three weeks to observe for growth. A single motile spirochete in ten fields of
view of darkfield microscopy at 400x magnification resulted in a sample being
scored as positive. If, after three additional weeks, no bacteria were observed in
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either the parent or passaged culture, that culture (and hence the tissue placed
therein) was scored as negative for B. burgdorferi.

Quantification of bacterial load in tissues
Total DNA was isolated from frozen tissues using the Qiagen DNeasy Blood
and Tissue kit as per manufacturers instructions. To re-suspend DNA in water, the
elution buffer from the kit was added to two volumes of 100% ethanol and 1/10
volume of 3M sodium acetate, stored at -20°C for at least one hour, spun down at
14,000 g for one hour, washed with 1mL of 70% ethanol without salt, spun again for
15 min, and the supernatant was removed and replaced by the desired quantity of
nuclease-free water. To quantify relative amounts of B. burgdorferi DNA to mouse
DNA, primers against the borrelial recA gene and mouse nidogen gene (249) were
used. Standard curves were used for the exact copy number of B. burgdorferi
genomes and nanograms of mouse DNA. These were determined by comparison to
purified B. burgdorferi DNA from culture and mouse DNA from a naïve animal,
respectively. qPCR was performed on the BioRad MyIQ2 quantitative thermal cycler
with the following conditions for both sets of primers: 95°C-3 min; 40 cycles of 95°C
-30 sec, 60°C-1 min; 55°C-1 min; and a melt curve of 60-90°C for 15 sec at each
temperature to verify product specificity.

Tick infections
Mice were infected for two weeks with the B. burgdorferi strains as detailed
in the results section. At two weeks post-infection, an ELSA was performed to verify

77

that the animals had been infected with bacteria (see protocol below). Mice that
were verified infected were fed on by larval Ixodes scapularis ticks, which were
obtained from the tick-rearing facilities at Oklahoma State University. To facilitate
proper attachment of ticks, mice were anesthetized by placing them in a jar with
volatilized isofluorane. While unconscious, the mice were briefly placed in a tube
with naïve larval ticks to allow for them to attach to the mice. To further guarantee
long-term tick attachment, the mice were placed in small individual restrainers
wrapped in damp cloth overnight. The following day, mice were released and
placed on a wire rack suspended inside a normal cage from which the bedding had
been emptied and replaced with water. During this time, mice were isolated, but
provided with food and water ad libitum. The water was changed daily, and ticks
were allowed to feed to repletion, at which point they were collected from the water
at the bottom of the cage and stored at 23°C in an incubator with 12 hour light/dark
cycles. Upon completion of the tick feeding, mice were sacrificed as above.
To assess whether ticks were successfully able to acquire B. burgdorferi, 5 fed
larvae from each mouse were used each for PCR analysis and culture. To culture,
ticks, they were placed in 500µL of BSKII plus rifampicin, ground as much as
possible with a pipet tip, and allowed to grow for up to three weeks. The culture
was assessed for growth as the mouse tissues were above. For PCR, DNA was
purified as for the mouse tissues above. Primers against the flaB gene (see Table 31) were used to test for B. burgdorferi DNA and IscaP16s primers against Ixodes
DNA were used to verify DNA quality. The following thermal cycler protocol was
used: 95°C-1 min; 35 cycles of 95°C-30 sec, 55°C-30 sec, 68°C-30 sec; 68°C-7 min,
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hold at 4°C. The enzyme used was rTaq (TaKaRa). A single positive culture or PCR
was used to score a mouse as positive in transmission of the spirochete to the tick.
To test the ability of B. burgdorferi to transmit from the tick to the mouse
during feeding, the larvae collected were allowed to molt to nymphs, and were fed
on new naïve mice similarly to the larval ticks. 15 infected nymphs were applied
per mouse, but usually approx. 8-10 fed ticks were recovered at the end of each
feeding cycle. To verify that mice fed on by infected ticks were, infected in turn, they
were sacrificed two weeks post feeding and their tissues were analyzed for bacterial
growth via culture in BSKII as detailed above.
Table 5-1) Loss of BB0347 does not result in gross defects in infectivity.
Bacterial strain

Dose

Positive mice

Positive tissues

100000
10000
1000
100

3/3
3/3
3/3
2/3

11/11
10/11
12/12
6/11

100000
10000
1000
100

3/3
3/3
3/3
2/3

12/12
11/12
12/12
6/12

Wild Type

bb0347 K/O

ELISAs
To verify that mice were infected prior to tick feeding, non-terminal mouse
sera were collected via puncture of the submandibular vein and collection of the
blood in heparin-coated tubes. All other steps in serum collection are detailed in the
materials and methods section of Chapter II. 96-well plates were coated with
10µg/mL whole B. burgdorferi 5A18NP1 lysate overnight at 4°C. Wells were then

79

blocked with 300µL 10% FBS for two hours at room temperature to prevent nonspecific binding of mouse antibodies. Sera were then diluted 1:100 and 100µL were
added to the wells for 1 hour at room temp. Secondary antibodies against mouse
IgG and IgM conjugated to horseradish peroxidase were then added to the wells for
one hour at room temp. Other steps in the ELISA were as described previously
(Chapter III materials and methods). Serum levels of cytokines and chemokines as
detailed in the results section were measured using R&D Systems Duoset ELISA kits
and protocols followed were as per manufacturer’s instructions.

Figure 5-1) BB0347 promotes enhanced bacterial tissue load. Mice were
infected with 105 spirochetes, and various tissues were collected at two weeks and
one month post-infection. Tissue load was determined by qPCR comparing B.
burgdorferi (Bb) to total mouse DNA. To determine whether differences in tissue
load were statistically significant, One-way ANOVA was performed. All numbers are
indicative of at least 5 independent animals, and error bars indicate ±SEM. *: p<0.05
compared to WT at the same time point post infection.
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Results
The infectivity of bb0347 mutants in needle-inoculated mice
Our first objective was to determine if lack of BB0347 resulted in gross
deficiencies in the ability of B. burgdorferi to infect the mammalian host. To achieve
this, we injected mice with BB0347 parent and KO strains of B. burgdorferi at
varying doses from 100-10,000 spirochetes per animal, and cultured organs from
these mice in BSKII two weeks post-inoculation (Table 5-1). We observed no
statistical difference between mice infected with the different B. burgdorferi strains
at this time point, suggesting no major defects in the spirochete’s ability to colonize
or survive in host tissues.

Figure 5-2) BB0347 does not aid in immune evasion. Global mouse immune
regulators were quantified via ELISA from mouse serum at two weeks post-infection
by B. burgdorferi 5A18NP1 (WT), bb0347 knockout (KO), bb0347 complemented
strain (comp) and uninfected mice. *: p<0.05 as determined by one-way ANOVA.
Groups are of at least 5 individual animals, and error bars indicate SEM.
To more precisely quantify the role of BB0347 in mouse infection, we next
used qPCR to measure the relative amount of B. burgdorferi in all the tissue types
previously used for culture (Fig. 5-1). By using qPCR we were able to detect
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differences in the tissue load at 2 weeks post-infection in several of the tissues
assessed, namely the hearts, bladder, and ears. No differences were seen in joints at
two weeks post-infection, and no organs showed differences after one month of
We next assessed whether mice infected with B. burgdorferi lacking BB0347
exhibited a difference in immune response to the pathogen. To do this we measured
global levels of CCL2 and Il-17 (Fig. 5-2). We also attempted to measure levels of
TNF-alpha, but no detectable amounts were present in mice infected with any strain
of the B. burgdorferi (data not shown). Our results indicated that the bb0347 KO
bacterium elicited a slightly less robust production of CCL2, and no detectable
difference in IL-17 production. Taken together, these data suggest that BB0347 is
not important for a reduction of the host immune response.
Table 5-2) BB0347 enhances bacterial uptake by ticks two weeks post-infection.
Strain
Ticks positive-PCR
Ticks positive-culture Mice infected by ticks
WT
bb0347 KO
Complement

10/10
4/10
6/6

5/5
2/5
N/A

5/5
5/5
N/A

The role of BB0347 in a “natural” B. burgdorferi life cycle
While the needle inoculations of mice with the various BB0347 strains
implicated the protein as important in the initial stages of an infection by B.
burgdorferi, the actual role of this protein in the bacterial life cycle remained
uncharacterized. Several phenomena may be detectable only by the tick-mouse
transmission cycle that are not evident during the needle inoculations. It may be
that the decreased initial tissue load would not adversely affect the bacterium’s
natural life cycle. Alternatively, the differences detected may be even stronger, as a
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tick feeding on a mouse will not result in such a large transfer of bacteria —105
spirochetes were used in the subcutaneous inoculation studies.
After analyzing ticks fed on infected mice, we found that there was a decrease
in the ability of ticks to recover bb0347 KO borreliae from infected mammals when
compared to the WT B. burgdorferi strain. To determine this, groups of 5 ticks from
each mouse were assessed by both PCR and culture. If one tick from a mouse
yielded a positive result, the animal was scored as positive. However, ticks from
mice that did transmit the bb0347 mutant bacteria were able to inoculate naïve mice
as well as ticks infected with the wild-type bacteria when tissues were analyzed by
culture (Table 5-2). Taken together, these data suggest a role for BB0347 in uptake
by Ixodes ticks, but BB0347 again demonstrates no major benefit in the infection of
mouse organs, at least to the level detectable by culture.

Effects of mlpJ deletion in a mouse infection
As we were able to utilize qPCR to determine the difference in tissue load
between bb0347 WT and mutant B. burgdorferi-infected mice, we next decided to
apply this protocol for a murine infection with mlpJ WT, KO, and complemented
strains. The strain used for the BB0347 infection experiments, 5A18NP1, is missing
the plasmid encoding for MlpJ (lp56), and displays infectivity similar to strains
which have this plasmid, such as 5A4NP1 when assessed by culture (194).
Therefore, we decided to forego the culture experiments as performed previously
and simply decided to examine infectivity by qPCR (Fig. 5-3). However, even when
using the more precise method of qPCR, tissue loads were comparable in the WT,
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KO, and complemented strains of mlpJ. These results indicate that MlpJ does not
have a detectable role in a murine infection under the parameters tested.

Figure 5-3) MlpJ deletion has no effect on bacterial tissue load in a mouse
infection. Mice infected with mlpJ WT, KO, or complemented bacteria have
equivalent levels of B. burgdorferi DNA as determined by qPCR analysis over one
month of infection.
Discussion
The analysis of protein factors important in the life cycle of the Lyme
spirochete may further our ability to treat infections by this bacterium. By using or
mouse model, we can replicate the challenges a population of B. burgdorferi
spirochetes would encounter during a normal life cycle. Some of the difficulties
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inherent in studying this pathogen include the proper use of an animal model (250)
and the apparent redundancy of ECM-binding proteins in the spirochete (124).
For example, while Fn-binding proteins have been found to be essential in
other pathogens, such as S. aureus (107), no essential Fn-binding proteins has been
found in B. burgdorferi. However, several of the known Fn-binding proteins have
been found to participate in the infectious process of the organism (126, 131). Our
studies have also found a role for the BB0347 protein in a B. burgdorferi murine
infection. If we had simply used the culture-based techniques to analyze the
infection, we would not have been able to detect differences in the bb0347 mutant
strain’s ability to infect. Thanks to advances in qPCR, the burden of a B. burgdorferi
infection can be more accurately quantified (251). Our finding that BB0347 is
required for an efficient infection of mice, and the subsequent passage to ticks
prompted the elucidation of the mechanism.
A murine infection by B. burgdorferi may be facilitated by an insufficient
immune response. This could be aided by a number of factors, but we have evidence
that the lack of one Fn-binding proteins, RevA, leads to an increase in serum levels
of CCL2, a pro-inflammatory chemokine (252) by a B. burgdorferi-infected organism,
and also results in increased tissue inflammation (131). By contrast, eliminating
BB0347 from invading spirochetes did not increase the serum levels of CCL2, nor of
the cytokine IL-17, also known to be important for inflammation during a B.
burgdorferi murine infection (253, 254). In fact, serum CCL2 levels were lower in
bb0347 KO treated mice compared to those of a bb0347 WT mouse, probably due to
the increased spirochete burden.
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Interestingly, the spirochete burdens measured in knee joints of the infected
mice were statistically equivalent in the bb0347 WT and KO strains, and joint was
the only tissue type examined without differences in the numbers of bacteria. This
is a different result than was obtained in an earlier paper examining a noninfectious strain of B. burgdorferi overexpressing bb0347, in which the only
difference in spirochete load was seen at the mouse tibiotarsal joint (133). Since
this paper could only use a short-term infection, as the B. burgdorferi strain was
non-viable in a mouse, this may account for the differences seen. It may be possible
that, at earlier time points, our model would also show a difference in this tissue
type, while not in the others (heart, distal skin, and bladder). The eventual recovery
of bb0347 KO bacterial loads in tissues to WT-equivalent levels is similar to the
phenomenon seen in another Fn-binding protein from the spirochete. Other studies
have shown that BBK32-deficient B. burgdorferi is delayed in its migration through
the mouse host, but eventually achieves parent strain-like distributions (129).
Application of this luminescent tracking strategy to BB0347-deficient bacteria in the
future may reveal a similar pattern of behavior.
The uptake of B. burgdorferi into ticks is a complex process, requiring, in
addition to general bacterial survival in the mammalian host, chemotaxis to and
from the tick feeding pit to allow transmission to the vector (255). While we found
that bb0347 KO-infected ticks were able to transmit the bacterium as effectively as
WT-infected ticks, there was a decrease in tick uptake of the KO B. burgdorferi
strain. The reason for this phenomenon is unclear, but may be due to the fact that
there is a severely decreased bacterial load in the KO-infected mice. In fact, the
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tissue type used to represent distal skin, the mouse ear, shows a 20-fold decrease in
bacterial load after two weeks in a bb0347 KO-infected mouse when compared to
the WT infection. As the ticks were fed on the mice at two weeks post-infection, this
times perfectly to the observed decrease in bacterial load.
The mlpJ knockout bacteria, on the other hand, showed no decrease in
bacterial load at any of the time points measured. We began surveillance of mice for
bacterial burden by qPCR at 3 days post infection, and continued to one month, and
were unable to detect differences in any tissue at any time. This aligns with the
observation that lp56 (and therefore mlpJ) deficient B. burgdorferi do not display
infectivity defects by direct culture of animal organs. Nevertheless, a similar
phenotype was observed in the bb0347 strain of the bacterium when using culture,
but qPCR analysis was more sensitive to tissue load differences.
The question then remains as to the function of MlpJ during a borrelial
infection. It may be possible that MlpJ (and lp56 in general) are not important in
mouse infections. If this is true, then is there a infection in which the protein is
important? Other hosts and models for the Lyme spirochete and its disease exist,
including birds, rabbits, and rhesus macaques. It’s likely that a B. burgdorferi
infecting these mammals would have a distinct set of challenges to overcome that
MlpJ would potentially be important in helping to accomplish. It is also known that
hemin modulates a number of different host pathways, both directly as a cofactor
and indirectly through production of ROS, including in the central nervous system
(256, 257). In such cases, perhaps the bacterium does not require MlpJ for survival,
but uses the protein to modulate immune response to allow for a more fit host.
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CHAPTER VI
CONCLUSION

The studies included herein detail some of the inherent complexities a
researcher encounters when working with B. burgdorferi. It’s not particularly novel
to suggest that modern biology is becoming more complex at an exponential rate.
As more information is learned, it must also be applied to the problem in focus to
substantially address any research question. The evolution of our knowledge of the
B. burgdorferi outer membrane is one such example. This borrelial outer membrane
is so highly populated with proteins that it has been described previously as a
“rainforest” (258). To add to this complexity, we have identified and verified two
new proteins that now join this extracellular milieu of molecules, and have
expanded the repertoire of molecules known to interact with specific borrelial
receptors.
While the proteins BB0347 and MlpJ are both surface exposed, they are also
both understudied. PubMed searches for the terms “BB0347” and “MlpJ” yield 3 and
0 relevant hits, respectively; although expanding the search terms for all mlp genes
results in several published articles concerning the family as a whole (146–148).
Accordingly, prior to these studies, almost no information was known regarding the
function of either protein. BB0347 has had some cursory work done on Fn binding
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(130), and a short term infection model in a non-infectious strain did show some
infectivity defects (133). However, our studies were the first to show localization of
the BB0347 protein to the outer surface of the bacterium as well as the first to
investigate mechanisms of binding and the role of BB0347 in a murine model of
infectious Lyme disease. Simultaneously, our work has been the first to characterize
the function of any of the Mlp proteins from B. burgdorferi, although the lack of an
infectivity phenotype in MlpJ-deficient bacteria was not particularly surprising, the
question remains as to why B. burgdorferi can lose a large section of its genome
(lp56-the plasmid that encodes for MlpJ, among other genes) without noticeable
defects in infectivity in a murine model (194). This is especially striking when one
considers the highly reduced genome of the bacterium (259), which means that
nearly 6% of the B31 strain’s genetic material is housed on a plasmid for which the
ecological function is unknown.
One expanding field in the study of Lyme disease is the potential for coinfections by other tick-borne pathogens (260–262). It may be that genes encoded
for by lp56 facilitate survival during such co-infections. Indeed, one of the genes
encoded by lp56, BBQ67, is a restriction endonuclease that may be used to prevent
uptake of foreign DNA, such as that which might be encountered during co-infection
of an Ixodes vector (194). Additionally, MlpJ, as a hemin-binding protein, might only
be necessary under periods of red blood cell lysis and subsequent hemin release.
While this may not normally occur during a pure borrelial infection, another
pathogen often transmitted with B. burgdorferi, Babesia microti, can induce massive
red blood cell lysis (263). Future studies of B. burgdorferi co-infections with B.
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microti may yield interesting results as well as a role for MlpJ (or lp56 in general)
under such circumstances.
Further characterizing the expression pattern of BB0347 may also explain
the phenomenon seen at later time points in which BB0347-deficient spirochetes
are able to reach bb0347 WT levels of bacterial burden. Technology exists to track
the bacterium as well as the expression of specific genes in a mouse infection using
transcriptional fusions to reporters (264). Also, further characterization of the
relationship between BB0347 and other outer membrane proteins may lead to more
insights in the bacterial physiology of the Lyme spirochete. One of the most novel
findings of the included studies regard the implication that at least several of the Fnbinding proteins are not redundant in function. Inactivating BB0347 did not result
in bacteria phenotypically resembling the revA mutant previously described (131),
nor was its function complemented by the mere presence of BBK32. To account for
these observations, many bacterial proteins can form dimers with other outer
membrane proteins, and it may be that BB0347 forms either homo or heterodimers
in situ. A BB0347-BBK32 heterodimer may help explain the phenomena seen
during the intact spirochete binding assays. These phenomena may also be
explained by a step-wise binding in which Fn bound by either BBK32 or BB0347 has
a higher affinity for the other protein. Future studies investigating multiple
simultaneous binding events of Fn by the borrelial proteins may be of interest.
Furthermore, our search for a singular Fn-binding site on BB0347 resulted
the discovery that multiple BB0347 regions are capable of independently
interacting with Fn. This result may provide insights into the function of the
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bacterial protein with respect to bacterial internalization or other binding
phenomena (113), which may, in turn, have important implications in the bacterial
life cycle and treatment paradigms. Further studies into the role of BB0347 in these
phenomena are already underway.
Overall both proteins merit further analyses to further define their roles in
Lyme infections. Elucidating these mechanisms, among others, may allow for more
precise understanding of B. burgdorferi infection mechanisms and the challenges the
bacterium faces en route to its desired sub-organismal niches and persistence there
once established. While these proteins may help achieve a bacterial “goal,” the fact
remains that these proteins are also possible hazards for the bacterium. Any
extracellular protein is an potential target for host pattern recognition receptors—
such as TLR1/2 for borrelial lipoproteins (54, 265, 266)—or antibodies. Indeed, as
we have shown here, antibodies in the serum of infected mice can recognize
BB0347, and the ability of patients to produce antibodies against MlpJ has been
shown previously (146).
We hope that this work can be used to further research into B. burgdorferi
infections to aid in the treatment of Lyme patients worldwide. Furthermore,
insights gained by studying Lyme pathogenesis may aid in the treatment of other
bacterial infections as well as non-infectious conditions; especially conditions
resulting from defects in the ECM. In fact, the ECM may be a prime target in the
future for treatment of various diseases, including Lyme (267).
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SUPPLEMENT

A(nother) Ode to Spirochetes
Stairway to Fibronectin
(With sincere and perfuse apologies to Led Zeppelin)

There’s a bug that swims sure
‘Cause it looks like a worm
And it's binding to host fibronectin

When it gets where it wants
You’ll have foggy thoughts
And maybe even severe arthritis

Ooh, ooh, ooh, ooh and it’s binding to your fibronectin

There’re white cells on the way
But you know it’s too late
This Lyme is already disseminated

92

In some brush by a stream
There’s a mouse that’s not clean
He’s got a major tick infestation

Ooh, it makes me itchy
Ooh, it makes me itchy

There’s a feeling I get
When I look at my West(ern blot)
And it’s got a bubble right on my protein

In my dreams I have seen
Countless spirochetes
And they love to swim past and taunt me

Ooh it makes me cranky
Ooh it really makes me hangry

And it’s whispered at night
If I learn how to write
I may someday get some funding
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As the project matures
I’m sad, to be sure
It’s all a bunch of negative data

<Mellow instrumental>

Your mind is foggy and it won’t go,
In case you don’t know
You’ve got to get some antibiotics

Dear Borrelia I’ll miss you
But not that much
Your proteins are a pain to make

<Sick guitar solo>

And this bug, it has a dream
To infect all living things
So be safe and wear your DEET
When you walk among the trees

And if you search over your bod
You’ll find a tick there that’s hard
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That’s given you a new friend
So you make take some time to mend
‘Cause this infection has no end

And it’s binding up all your fibronectin
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